0001079973-20-000888.txt : 20201016 0001079973-20-000888.hdr.sgml : 20201016 20201016085037 ACCESSION NUMBER: 0001079973-20-000888 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 48 CONFORMED PERIOD OF REPORT: 20200930 FILED AS OF DATE: 20201016 DATE AS OF CHANGE: 20201016 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ProtoKinetix, Inc. CENTRAL INDEX KEY: 0001128189 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943355026 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-32917 FILM NUMBER: 201243061 BUSINESS ADDRESS: STREET 1: 412 MULBERRY STREET CITY: MARIETTA STATE: OH ZIP: 45750 BUSINESS PHONE: 304-299-5070 MAIL ADDRESS: STREET 1: 412 MULBERRY STREET CITY: MARIETTA STATE: OH ZIP: 45750 FORMER COMPANY: FORMER CONFORMED NAME: RJV NETWORK INC DATE OF NAME CHANGE: 20010130 10-Q 1 pktx_10q-093020.htm FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

 

FORM 10-Q

 

☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2020

 

OR

☐  TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _____________ to ___________________.

 

Commission File Number: 000-32917

 

 

PROTOKINETIX, INCORPORATED

(Exact name of registrant as specified in its charter) 

 

 

Nevada   94-3355026
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)

 

 

412 Mulberry St.

Marietta, Ohio 45750

  
  (Address of principal executive offices, including zip code)  

 

  (Registrant’s telephone number, including area code: 740-434-5041)  

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol   Name of each exchange on which registered
N/A        

 

Securities registered pursuant to Section 12(b) of the Act:

 

$.0000053 par value common stock

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act:  ☐   Yes   ☒  No

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act:   ☐   Yes   ☒  No

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   ☒     Yes   ☐  No

 

 

 

 
 

 

 

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒   Yes      ☐   No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer , or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐     Accelerated filer  ☐
Non-accelerated filer ☐   Smaller reporting company ☒
Emerging growth company  ☐    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).        Yes ☐  No ☒

 

As of October 16, 2020, there were 281,596,071 shares of ProtoKinetix, Incorporated common stock that were issued and outstanding.

 

 

 

2 
 

 

PROTOKINETIX, INCORPORATED

TABLE OF CONTENTS

 

 

PART I  
   
FINANCIAL INFORMATION  
   
Item 1. Financial Statements 4
   
Unaudited Balance Sheets 4
   
Unaudited Statements of Operations 5
   
Unaudited Statement of Stockholders’ Equity 6
   
Unaudited Statements of Cash Flows 8
   
Notes to Unaudited Financial Statements 9
   

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of

Operations

 21
   
Item 3. Quantitative and Qualitative Disclosures About Market Risk 25
   
Item 4. Controls and Procedures 25
   
PART II  
   
OTHER INFORMATION  
   
Item 1. Legal Proceedings 26
   
Item 1A. Risk Factors 26
   
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 27
   
Item 3. Defaults Upon Senior Securities 27
   
Item 4. Mine Safety Disclosure 27
   
Item 5. Other Information 27
   
Item 6. Exhibits 28
   
Signatures 29

 

 

3 
 

PROTOKINETIX, INCORPORATED

(A Development Stage Company)

BALANCE SHEETS

(Unaudited)

 

   September 30, 2020  December 31, 2019
ASSETS          
Current Assets          
Cash  $44,763   $377,349 
Prepaid expenses (Note 3)   1,050    1,050 
Total current assets   45,813    378,399 
           
Intangible assets (Note 4)   250,638    207,508 
           
Total assets  $296,451   $585,907 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
Current Liabilities          
Accounts payable and accrued liabilities  $5,000   $25,520 
           
Total current liabilities  $5,000   $25,520 
Stockholders’ Equity          
Common stock, $0.0000053 par value; 400,000,000 common shares authorized; 281,596,071 and 275,400,259 shares issued and outstanding as at September 30, 2020 and December 31, 2019 respectively (Note 7)   1,506    1,472 
Additional paid-in capital   42,900,764    36,107,058 
Accumulated deficit   (42,610,819)   (35,548,143)
Total stockholders’ equity   291,451    560,387 
Total liabilities and stockholders’ equity  $296,451   $585,907 
           

Basis of Presentation – Going Concern Uncertainties (Note 1)

Commitments and Contingency (Note 9)

 

 

See Notes to Financial Statements

 

4 
 

 

 

PROTOKINETIX, INCORPORATED

(A Development Stage Company)

STATEMENTS OF OPERATIONS

(Unaudited)

For the Three and Nine Months Ended September 30, 2020 and 2019

 

    Three months ended
September 30, 2020		   Three months ended
September 30, 2019		   Nine months ended
September 30, 2020		   Nine months ended
September 30, 2019
                 
EXPENSES                                
    Amortization – intangible assets (Note 4)   $ 750     $ 750     $ 2,250     $ 2,250  
General and administrative     46,460       76,905       174,480       202,238  
Professional fees     39,063       31,032       116,112       92,315  
Research and development     142,221       140,933       438,544       279,089  
Share-based compensation (Notes 5 and 8)     1,458,990       342,218       6,331,290       1,167,629  
                                 
      (1,687,484 )     (591,838 )     (7,062,676 )     (1,743,521 )
 OTHER ITEM                                
    Foreign exchange gain or (loss)             (90 )      —         (106 )
                                 
Net loss for the period     (1,687,484 )     (591,928 )     (7,062,676 )     (1,743,627 )
Net loss per common share (basic and diluted)     (0.01 )     (0.00 )     (0.03 )     (0.01 )
                                 
Weighted average number of common shares outstanding (basic and diluted)     279,648,342       272,816,256       277,211,051       267,232,714  

 

 

 

 

 

 

See Notes to Financial Statements

 

 

5 
 

 

 

PROTOKINETIX, INCORPORATED

STATEMENT OF STOCKHOLDERS’ EQUITY

(Unaudited)

For the Period from January 1, 2020 to September 30, 2020

 

 

    Common Stock   Additional Paid-in   Accumulated    
    Shares   Amount   capital   deficit   Total
Balance, December 31, 2019     275,400,259     $ 1,472     $ 36,107,058     $ (35,548,143 )   $ 560,387  
Issuance of common stock pursuant to private placement offering     6,195,812       34       462,416       —         462,450  
Fair value of share-based compensation     —         —         6,331,290       —         6,331,290  
Net loss for the period     —         —         —         (7,062,676 )     (7,062,676 )
Balance, September 30, 2020     281,596,071     $ 1,506     $ 42,900,764     $ (42,610,819 )   $ 291,451  
                                         
Balance, June 30, 2020     277,622,481     $ 1,484     $ 41,179,346     $ (40,923,335 )   $ 257,495  
Issuance of common stock pursuant to private placement offering    

 

3,973,590

       22       262,428       —         262,450  
Fair value of share-based compensation     —         —         1,458,990       —         1,458,990  
Net loss for the period     —         —         —         (1,687,484 )     (1,687,484 )
Balance, September 30, 2020     281,596,071     $ 1,506     $ 42,900,764     $ (42,610,818 )   $ 291,451  

 

 

 

 

6 
 

 

PROTOKINETIX, INCORPORATED

STATEMENT OF STOCKHOLDERS’ EQUITY

(Unaudited)

For the Period from January 1, 2020 to September 30, 2020

 

 

    Common Stock   Additional Paid-in   Accumulated    
    Shares   Amount   capital   deficit   Total
Balance, December 31, 2018     259,785,766     $ 1,389     $ 31,594,822     $ (31,350,246 )   $ 245,965  
Issuance of common stock pursuant to private placement offering     13,016,667       69       816,931       —         817,000  
Issuance of common stock pursuant to cashless option exercise     97,826       1       (1)       —         —    
Share-based compensation     —         —         1,167,629       —         1,167,629  
Loss for the period     —         —         —         (1,743,627 )     (1,151,699 )
Balance, September 30, 2019     272,900,259     $ 1,459     $ 33,579,381     $ (33,093,873 )   $ 486,967  
                                         
Balance, June 30, 2019     272,802,433     $ 1,458     $ 33,237,164     $ (32,501,945 )   $ 736,677  
Issuance of common stock pursuant to cashless option exercise     97,826       1       (1)       —         —    
Share-based compensation     —         —         342,218       —         342,218  
Loss for the period     —         —         —         (591,928 )     (591,928 )
Balance, September 30, 2019     272,900,259     $ 1,459     $ 33,579,381     $ (33,093,873 )   $ 486,967  

 

 

 

See Notes to Financial Statements

 

7 
 

PROTOKINETIX, INCORPORATED

(A Development Stage Company)

STATEMENTS OF CASH FLOWS

(Unaudited)

For the Nine Months Ended September 30, 2020 and 2019

 

    Nine Months ended
September 30, 2020		   Nine Months ended
September 30, 2019
         
CASH FLOWS USED IN OPERATING ACTIVITIES                
Net loss for the period   $ (7,062,676 )   $ (1,743,627 )
Adjustments to reconcile net loss to cash used in operating activities:                
Amortization – intangible assets     2,250       2,250  
Fair value of share-based compensation     6,331,290       1,167,629  
Changes in operating assets and liabilities:                
Prepaid expenses     —         (9,540 )
Accounts payable and accrued liabilities     (20,520 )     (73,464 )
                 
Net cash used in operating activities     (749,656 )     (656,752 )
                 
CASH FLOWS USED IN INVESTING ACTIVITIES                
Purchase of intangible assets     (45,380 )     (6,418 )
                 
Net cash used in investing activities     (45,380 )     (6,418 )
                 
                 
CASH FLOWS FROM FINANCING ACTIVITIES                
Issuance of common stock for cash     462,450       817,000  
                 
Net cash from financing activities     462,450       817,000  
                 
Net change in cash     (332,586 )     153,830  
                 
Cash, beginning of period     377,349       136,029  
                 
Cash, end of period   $ 44,763     $ 289,859  
                 
Cash paid for interest   $ —       $ —    
                 
Cash paid for income taxes   $ —       $ —    
                 

 

See Notes to Financial Statements

 

 

8 
 

PROTOKINETIX, INCORPORATED

(A Development Stage Company)

 

NOTES TO FINANCIAL STATEMENTS

September 30, 2020

 

Note 1.  Basis of Presentation – Going Concern Uncertainties

 

ProtoKinetix, Incorporated (the “Company”), a development stage company, was incorporated under the laws of the State of Nevada on December 23, 1999.  The Company is a medical research company whose mission is the advancement of human health care.

 

The Company is currently researching the benefits and feasibility of synthesized Antifreeze Glycoproteins (“AFGP”) or anti-aging glycoproteins, trademarked AAGP.  During the year ended December 31, 2015, the Company acquired certain patents and rights for cash consideration of $30,000 (25,000 Euros), as well as additional patent applications for cash consideration of $10,000 and 6,000,000 share purchase warrants with a fair value of $25,000 (Note 4).

 

The Company’s financial statements are prepared consistent with accounting principles generally accepted in the United States applicable to a going concern.

 

The Company has not developed a commercially viable product, has not generated any significant revenue to date, and has incurred losses since inception, resulting in a net accumulated deficit at September 30, 2020.  These factors raise substantial doubt about the Company’s ability to continue as a going concern.

 

The Company needs additional working capital to continue its medical research or to be successful in any future business activities and continue to pay its liabilities.  Therefore, continuation of the Company as a going concern is dependent upon obtaining the additional working capital necessary to accomplish its objective.  Management is presently engaged in seeking additional working capital through equity financing or related party loans.

 

In March 2020, the World Health Organization declared coronavirus COVID-19 a global pandemic. This contagious disease outbreak, which has continued to spread, and any related adverse public health developments, has adversely affected workforces, economies, and financial markets globally, potentially leading to an economic downturn. It is not possible for the Company to predict the duration or magnitude of the adverse results of the outbreak and its effects on the Company’s business or ability to raise funds.

 

The accompanying financial statements do not include any adjustments to the recorded assets or liabilities that might be necessary should the Company fail in any of the above objectives and is unable to operate for the coming year.

 

Note 2. Summary of Significant Accounting Policies

 

Basis of Presentation

 

The accompanying unaudited financial statements have been prepared by the Company in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) applicable to interim financial information and with the rules and regulations of the United States Securities and Exchange Commission. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed, or omitted, pursuant to such rules and regulations. In the opinion of management, the unaudited interim financial statements include all adjustments necessary for the fair presentation of the results of the interim periods presented. All adjustments are of a normal recurring nature, except as otherwise noted below. These financial statements should be read in conjunction with the Company’s audited financial statements and notes thereto for the year ended December 31, 2019, included in the Company’s Annual Report on Form 10-K, filed February 19, 2020, with the Securities and Exchange Commission. The results of operations for the interim periods are not necessarily indicative of the results of operations for any other interim period or for a full fiscal year.

 

 

9 
 

 

 

PROTOKINETIX, INCORPORATED

(A Development Stage Company)

 

NOTES TO FINANCIAL STATEMENTS

September 30, 2020

 

Note 2. Summary of Significant Accounting Policies (cont’d)

 

Use of Estimates

 

Preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period.  Actual results could differ from those estimates.  The more significant accounting estimates inherent in the preparation of the Company’s financial statements include estimates as to valuation of equity related instruments issued, deferred income taxes, and the useful life and impairment of intangible assets.

 

Cash

 

Cash consists of funds held in checking accounts.  Cash balances may exceed federally insured limits from time to time.

 

Fair Value of Financial Instruments

 

Financial instruments, which includes cash and accounts payable and accrued liabilities, are carried at cost, which management believes approximates fair value due to the short-term nature of these instruments.

 

The Company measures the fair value of financial assets and liabilities pursuant to ASC 820 “Fair Value Measurements and Disclosures” which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. ASC 820 establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The policy describes three levels of inputs that may be used to measure fair value:

 

Level 1 – quoted prices in active markets for identical assets or liabilities

Level 2 – quoted prices for similar assets and liabilities in active markets or inputs that are observable

Level 3 – inputs that are unobservable (for example cash flow modeling inputs based on assumptions)

 

Level 1 inputs are used to measure cash. At September 30, 2020, there were no other assets or liabilities subject to additional disclosure.

 

Income Taxes

 

The Company accounts for income taxes following the assets and liability method in accordance with the ASC 740 “Income Taxes.”  Under such method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases.  The Company applies the accounting guidance issued to address the accounting for uncertain tax positions.  This guidance clarifies the accounting for income taxes, by prescribing a minimum recognition threshold a tax position is required to meet before being recognized in the financial statements as well as provides guidance on derecognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years that the asset is expected to be recovered or the liability settled.

 

10 
 

 


 

PROTOKINETIX, INCORPORATED

(A Development Stage Company)

 

NOTES TO FINANCIAL STATEMENTS

September 30, 2020

 

Note 2. Summary of Significant Accounting Policies (cont’d)

 

Intangible assets – patent and patent application costs

 

The Company owns intangible assets consisting of certain patents and patent applications. Intangible assets acquired separately are measured on initial recognition at cost. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and any accumulated impairment losses. Subsequent expenditures are capitalized only when they increase the future economic benefits embodied in the specific asset to which they relate. All other expenditures are recognized in profit or loss as incurred.

 

As at September 30, 2020, the Company does not hold any intangible assets with indefinite lives.

 

Intangible assets with finite lives are amortized over the useful economic life and assessed for impairment whenever there is an indication that the intangible asset may be impaired. The amortization method and amortization period of an intangible asset with a finite life is reviewed at least annually.

 

Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset is accounted for by changing the amortization period or method, as appropriate, and are treated as changes in accounting estimates. Amortization is recognized in profit or loss on a straight-line basis over the estimated useful lives of the Company’s patents. No amortization is recognized on patent application costs, as amortization of these costs will only commence once the patents have been granted.

 

Research and Development Costs

 

Research and development costs are expensed as incurred.

 

Loss per Share and Potentially Dilutive Securities

 

Basic loss per share is computed by dividing the net loss available to common stockholders by the weighted average number of common shares outstanding in the period.  Diluted loss per share takes into consideration common shares outstanding (computed under basic earnings per share) and potentially dilutive securities.  The effect of 83,100,000 stock options (September 30, 2019 – 76,450,000), and 8,500,000 warrants (September 30, 2019 – 6,000,000) were not included in the computation of diluted earnings per share for all periods presented because it was anti-dilutive due to the Company’s losses.

 

Share-Based Compensation

 

The Company has granted warrants and options to purchase shares of the Company’s common stock to various parties for consulting services.  The fair values of the warrants and options issued have been estimated using the Black-Scholes Option Pricing Model.

 

The Company accounts for stock compensation with persons classified as employees for accounting purposes in accordance with ASC 718 “Compensation – Stock Compensation”, which recognizes awards at fair value on the date of grant and recognition of compensation over the service period for awards expected to vest. Cliff Vesting is used and awards vest on the last day of the vesting period. The fair value of stock options is determined using the Black-Scholes Option Pricing Model. The fair value of common shares issued for services is determined based on the Company’s stock price on the date of issuance.

 

11 
 

 

 

PROTOKINETIX, INCORPORATED

(A Development Stage Company)

 

NOTES TO FINANCIAL STATEMENTS

September 30, 2020

 

Note 2. Summary of Significant Accounting Policies (cont’d)

 

Share-Based Compensation (cont’d)

 

Share-based compensation for non-employees in exchange for goods and services used or consumed in an entity’s own operations are also recorded at fair value on the measurement date and accounted for in accordance with ASC 718. The measurement of share-based compensation is subject to periodic adjustment as the underlying instruments vest. The fair value of stock options is estimated using the Black-Scholes Option Pricing Model and the compensation charges are amortized over the vesting period.

 

Common stock

 

Common stock issued for non-monetary consideration are recorded at their fair value on the measurement date and classified as equity. The measurement date is defined as the earliest of the date at which the commitment for performance by the counterparty to earn the common shares is reached or the date at which the counterparty’s performance is complete.

 

Transaction costs directly attributable to the issuance of common stock, units and stock options are recognized as a deduction from equity, net of any tax effects.

 

Related Party Transactions

 

A related party is generally defined as (i) any person that holds 10% or more of the Company’s securities and their immediate families, (ii) the Company’s management, (iii) someone that directly or indirectly controls, is controlled by or is under common control with the Company, or (iv) anyone who can significantly influence the financial and operating decisions of the Company.  A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties.

 

Recent Accounting Pronouncements

 

Certain new accounting pronouncements that have been issued are not expected to have a material effect on the Company’s financial statements.

 

12 
 

 

 

PROTOKINETIX, INCORPORATED

(A Development Stage Company)

 

NOTES TO FINANCIAL STATEMENTS

September 30, 2020

 

 

Note 3.   Prepaid Expenses

 

The following summarizes the Company’s prepaid expenses outstanding as at September 30, 2020 and December 31, 2019:

 

   September 30,
 2020		  December 31,
  2019
       
Rental deposit  $1,050   $1,050 
           
   $1,050   $1,050 

 

 

 

 

 

13 
 

 

PROTOKINETIX, INCORPORATED

(A Development Stage Company)

 

NOTES TO FINANCIAL STATEMENTS

September 30, 2020

 

Note 4.   Intangible Assets

 

Intangible asset transactions are summarized as follows:

 

    Patent Rights   Patent Application Rights   Total
Cost                        
Balance, December 31, 2018   $ 30,000     $ 168,271     $ 198,271  
Additions     —         22,737       22,737  
Balance, December 31, 2019   $ 30,000     $ 191,008     $ 221,008  
Additions     —         45,380       45,380  
Balance, September 30, 2020   $ 30,000     $ 236,388     $ 266,388  
                         
Accumulated amortization                        
Balance, December 31, 2018   $ 10,500     $ —       $ 10,500  
Amortization     3,000       —         3,000  
Balance, December 31, 2019   $ 13,500     $ —       $ 13,500  
Amortization     2,250       —         2,250  
Balance,September 30, 2020   $ 15,750     $ —       $ 15,750  
                         
Net carrying amounts                        
December 31, 2019   $ 16,500     $ 191,008     $ 207,508  
September 30, 2020   $ 14,250     $ 236,388     $ 250,638  

 

During the year ended December 31, 2015, the Company entered into an Assignment of Patents and Patent Application (effective January 1, 2015) (the “Patent Assignment”) with the Institut National des Sciences Appliquees de Rouen (“INSA”) for the assignment of certain patents and all rights associated therewith (the “Patents”). The Company and INSA had previously entered into a licensing agreement for the Patents in August 2004. The Patent Assignment transfers all of the Patents and rights associated therewith to the Company, upon payment to INSA in the sum of $30,000. During the nine month period ended September 30, 2020, the Company recorded $2,250 (2019 - $2,250) in amortization expense associated with the Patents.

 

During the year ended December 31, 2015, the Company entered into a Technology Transfer Agreement with Grant Young for the assignment of his 50% ownership of certain patents and all rights associated therewith (the “Patent Application Rights”).  In exchange for the Patent Application Rights, the Company agreed to pay $10,000 (paid) and to issue 6,000,000 warrants (issued) to purchase shares of the Company’s common stock at an exercise price of $0.10 per share for a period of five years. The Patent Application Rights had a total fair value of $35,000, which was allocated as $10,000 to the cash consideration paid, with the remaining $25,000 being allocated to the warrant component of the overall consideration. The Company has incurred $201,388 in direct costs relating to the Patent Application Rights, $45,380 of which were incurred during the nine month period ended September 30, 2020.

 

The remaining 50% ownership of the Patent Application Rights was acquired from the Governors of the University of Alberta in exchange for a future gross revenue royalty.

 

14 
 

 

 

 

PROTOKINETIX, INCORPORATED

(A Development Stage Company)

 

NOTES TO FINANCIAL STATEMENTS

September 30, 2020

 

Note 4.  Intangible Assets (cont’d)

 

During the year ended December 31, 2016, the Company entered into a Universal Assignment with Grant Young for the assignment of his ownership of certain new and useful improvements in an invention entitled “Use of Anti-Aging Glycoprotein for Enhancing Survival of Neurosensory Precursor Cells” (the “New Patent Application Rights”).  In exchange for the New Patent Application Rights, the Company agreed to pay $1 (paid).  The Company incurred $2,415 in direct costs relating to the New Patent Application Rights during the year ended December 31, 2016.

 

No amortization was recorded on the Patent Application Rights to September 30, 2020.

 

 

Note 5.  Stock Options

Pursuant to an amendment on April 6, 2020, the aggregate number of shares that may be issued under the 2017 Stock Option and Stock Bonus Plan (the “2017 Plan”) is 85,700,000 shares, subject to adjustment as provided therein. The 2017 Plan is administered by the Company’s Board of Directors, or a committee appointed by the Board of Directors, and includes two types of options. Options intended to qualify as incentive stock options under Section 422 of the Internal Revenue Code of 1986, as amended, are referred to as incentive options. Options that are not intended to qualify as incentive options are referred to as non-qualified options. The exercise price of an option may be paid in cash, in shares of the Company's common stock or other property having a fair market value equal to the exercise price of the option, or in a combination of cash, shares, other securities and property.

As of September 30, 2020, there are 83,100,000 options granted and outstanding under the 2017 Plan.

 

15 
 

 

PROTOKINETIX, INCORPORATED

(A Development Stage Company)

 

NOTES TO FINANCIAL STATEMENTS

September 30, 2020

 

 

Note 5.  Stock Options (cont’d)

 

Stock option transactions are summarized as follows:

    Number of Stock Options   Weighted Average Exercise Price   Weighted Average Remaining Life
        $   (Years)
Outstanding, December 31, 2019     91,450,000       0.14          
      Options cancelled     (36,000,000 )     0.13          
      Options expired     (2,000,000 )     0.04          
      Options granted     29,650,000       0.13          
Outstanding, September 30, 2020     83,100,000       0.15       4.23  
                         

 

    Number of Stock Options   Weighted Average Exercise Price   Weighted Average Remaining Life
        $   (Years)
Outstanding, December 31, 2018     58,600,000       0.07          
      Options cancelled     (16,000,000 )     0.07          
      Options exercised     (250,000 )      0.07          
      Options granted     34,100,000       0.25          
Outstanding, September 30, 2019     76,450,000       0.15       3.48  

 

 

 

16 
 

 

 

PROTOKINETIX, INCORPORATED

(A Development Stage Company)

 

NOTES TO FINANCIAL STATEMENTS

September 30, 2020

 

Note 5.  Stock Options (cont’d)

 

On May 6, 2020, the Company granted 650,000 stock options to a research and development, and a business development consultant of the Company. The options are exercisable at $0.11 per share for a period of six years and expire on May 5, 2026. The options vest in equal instalments starting on the date of grant with the remaining options vesting on a quarterly basis beginning on June 30, 2020.

The Company granted 22,000,000 replacement options and 7,000,000 replacement options on March 26, 2020 and June 12, 2020, respectively, to certain key management (Note 8) and a consultant (Note 9) of the Company. Total share-based compensation for 29,650,000 stock options granted (2019 - 34,100,000) and vested during the nine month period ended September 30, 2020 was $6,331,290 (2019 - $1,167,629) at a weighted average fair value per option of $0.12 (2019 - $0.07). The fair values of the stock options granted were estimated using the Black-Scholes Option Pricing Model, based on the following weighted average assumptions:

 

    September 30, 2020   September 30, 2019
Risk-free interest rate     2.55 %     2.41 %
Dividend yield     0.00 %     0.00 %
Expected stock price volatility     143.57 %     125.00 %
Expected forfeiture rate     0.00 %     0.00 %
Expected life     5.09 years       4.60 years  
                 

 

The following non-qualified stock options were outstanding and exercisable at September 30, 2020:

 

Expiry date   Exercise Price   Number of Options
Outstanding		   Number of
Options
Exercisable
    $        
December 31, 2020     0.05       1,200,000       1,200,000  
November 14, 2021     0.07       750,000       750,000  
December 31, 2022     0.06       800,000       800,000  
August 31, 2023     0.08       600,000       600,000  
November 8, 2023     0.09       15,000,000       15,000,000  
May 5, 2023     0.13       1,600,000       1,600,000  
July 14, 2024     0.26       18,500,000       18,500,000  
November 17, 2024     0.11       15,000,000       11,250,000  
March 26, 2026     0.14       22,000,000       22,000,000  
May 5, 2026     0.11       650,000       487,500  
June 11, 2026     0.12       7,000,000       7,000,000  
              83,100,000       79,187,500  

 

As at September 30, 2020, the aggregate intrinsic value of the Company’s stock options is $458,165 (December 31, 2019 – $1,005,350).

 

17 
 

 

PROTOKINETIX, INCORPORATED

(A Development Stage Company)

 

NOTES TO FINANCIAL STATEMENTS

September 30, 2020

 

Note 6.  Warrants

 

Warrant transactions for the nine months ended September 30, 2020 are summarized as follows:

 

    Number of
Warrants		   Weighted
Average Exercise
Price
         
  Balance,December 31, 2018 and September 30, 2019       6,000,000     $ 0.26  
  Balance, December 31, 2019 and September 30, 2020       8,500,000     $ 0.22  

 

 

The following warrants were outstanding and exercisable as at September 30, 2020:

 

Number of Warrants   Exercise Price ($)   Expiry Date
  6,000,000       0.26     July 14, 2024
  833,333       0.12     October 15, 2022
  250,000       0.12     October 21, 2022
  116,667       0.12     November 11, 2022
  83,334       0.12     November 12, 2022
  833,333       0.12     December 1, 2022
  166,667       0.12     December 18, 2022
  216,666       0.12     December 18, 2022
  8,500,000              

 

 

Note 7.  Stockholders’ Equity

 

The Company is authorized to issue 400,000,000 (December 31, 2019 – 400,000,000) shares of $0.0000053 par value common stock. Each holder of common stock has the right to one vote but does not have cumulative voting rights. Shares of common stock are not subject to any redemption or sinking fund provisions, nor do they have any preemptive, subscription or conversion rights. Holders of common stock are entitled to receive dividends whenever funds are legally available and when declared by the board of directors, subject to the prior rights of holders of all classes of stock outstanding having priority rights as to dividends. No dividends have been declared or paid as of September 30, 2020 (December 31, 2019 - $nil).

 

During the nine month period ended September 30, 2020, the Company:

 

a)Issued 2,222,222 shares of common stock to investors at $0.09 for gross proceeds of $200,000.
b)Issued 320,513 shares of common stock to investors at $0.078 for gross proceeds of $25,000.
c)Issued 3,653,077 shares of common stock to investors at $0.065 for gross proceeds of $237,450.

 

During the nine month period ended September 30, 2019, the Company:

 

  a) Issued 750,000 shares of common stock to investors at $0.06 for gross proceeds of $45,000.

  b) Issued 10,000,000 shares of common stock to investors at $0.05 for gross proceeds of $500,000.

  c) Issued 2,266,667 shares of common stock to investors at $0.12 for gross proceeds of $272,000.
  d) Issued 97,826 shares of common stock to the CFO pursuant to a cashless exercise of 250,000 stock options.

 

18 
 

 

 

PROTOKINETIX, INCORPORATED

(A Development Stage Company)

 

NOTES TO FINANCIAL STATEMENTS

September 30, 2020

 

Note 8. Related Party Transactions and Balances

 

During the nine month period ended September 30, 2020 and 2019, the Company entered into the following related party transactions:

a) Pursuant to a consulting agreement with an effective date of November 14, 2017, a total of $45,000 (2019 - $45,000) was paid or accrued to the Company's CFO. During the nine months ended September 30, 2020, the Company reimbursed a company controlled by the CFO a total of $9,450 (2019 - $9,450) in office rent.

b) On March 25, 2020, the Company cancelled and concurrently approved for issuance on March 26, 2020 10,000,000 stock options and 2,000,000 stock options previously issued to the Company’s CEO and a Director of the Company in 2017, respectively. The 12,000,000 replacement options granted have a term of 6 years and are exercisable at a price of $0.14 per share, expiring on March 25, 2026.

Also on March 25, 2020, the Company cancelled an additional 5,000,000 stock options previously issued to the Company’s CEO in 2019. There were no replacement options granted in connection with these cancelled options.

In accordance with ASC 718, the 12,000,000 replacement options were accounted for as a modification of the terms of the cancelled award, with the incremental cost being measured as the excess of the fair value of the replacement options over the fair value of the cancelled options at the cancellation date.

Total share-based compensation of $282,844 was recorded in connection with the option modification, based on the following assumptions used in the Black-Scholes Option Pricing Model: risk-free interest rate of 1.76%; dividend yield of 0.00%; stock price volatility of 144.40%; forfeiture rate of 0%; and an expected life of 6 years.

b) On June 12, 2020, the Company cancelled 4,000,000 stock options previously issued in July 2019 to the Company’s CFO and a replaced them with 3,500,000 stock options. The 3,500,000 replacement options granted have a term of 6 years and are exercisable at a price of $0.12 per share, expiring on June 11, 2026.

The 3,500,000 replacement options were accounted for as a modification of the terms of the cancelled award, with the incremental cost being measured as the excess of the fair value of the replacement options over the fair value of the cancelled options at the cancellation date.

Total share-based compensation of $5,704 was recorded in connection with the option modification, based on the following assumptions used in the Black-Scholes Option Pricing Model: risk-free interest rate of 1.76%; dividend yield of 0.00%; stock price volatility of 144.75%; forfeiture rate of 0%; and an expected life of 6 years.

c) The Company recognized $3,233,377 (2019 - $502,795) in share-based compensation during the period associated with stock options granted to key management personnel.

As at September 30, 2020 and December 31, 2019, there were $nil balances owing to related parties.

 

19 
 

 

 PROTOKINETIX, INCORPORATED

(A Development Stage Company)

 

NOTES TO FINANCIAL STATEMENTS

September 30, 2020

 

Note 9.  Commitments and Contingency

 

As at September 30, 2020, the Company has the following commitments:

 

a) Entered into a consulting agreement with an effective date of January 1, 2017 whereby the Company would pay the consultant $7,000 per month for providing research and development services. On March 25, 2020, the Company cancelled and concurrently approved for issuance on March 26, 2020, 10,000,000 stock options previously issued to the consultant in 2017. The 10,000,000 replacement options granted have a term of 6 years and are exercisable at a price of $0.14 per share, expiring on March 25, 2026.

The 10,000,000 replacement options were accounted for as a modification of the terms of the cancelled award, with the incremental cost being measured as the excess of the fair value of the replacement options over the fair value of the cancelled options at the cancellation date.

Total share-based compensation of $235,703 was recorded in connection with the option modification based on the following assumptions used in the Black-Scholes Option Pricing Model: risk-free interest rate of 0.81%; dividend yield of 0.00%; stock price volatility of 144.40%; forfeiture rate of 0%; and an expected life of 6 years.

On June 12, 2020, the Company cancelled 4,000,000 stock options previously issued in July 2019 to the consultant and a replaced them with 3,500,000 stock options. The 3,500,000 replacement options granted have a term of 6 years and are exercisable at a price of $0.12 per share, expiring on June 11, 2026. There was no incremental cost recorded on the option modification based on the following assumptions used in the Black-Scholes Option Pricing Model: risk-free interest rate of 1.76%; dividend yield of 0.00%; stock price volatility of 144.75%; forfeiture rate of 0%; and an expected life of 6 years.

b) Entered into a consulting agreement effective January 1, 2018, whereby the Company would pay the consultant $1,000 per month for a term of 1 year for providing public relations services, unless otherwise terminated by either party with at least 30 days’ notice.

c) Entered into a consulting agreement effective April 1, 2019, whereby the Company would pay the consultant $1,500 per month minimum plus travel expenses for a term of 1 year for providing research consulting services, unless otherwise terminated by either party with at least 30 days’ notice. On May 6, 2020, the Company granted the consultant 500,000 stock options exercisable at a price of $0.11 per share, expiring on May 5, 2026 (Note 5).

d) Entered into a consulting agreement effective September 1, 2020, whereby the Company would pay the consultant CAD $3,000 per month for a term of 1 year for providing technical expertise and public relations services, unless otherwise terminated by either party with at least 30 days’ notice.

Contingency

 

The Company was delinquent in filing certain income tax returns with the U.S. Internal Revenue Service and reports disclosing its interest in foreign bank accounts on form TDF 90-22.1, "Report of Foreign Bank and Financial Accounts" ("FBARs"). In September 2015, the Company filed the delinquent income tax returns and has sought waivers of any penalties under the IRS Offshore Voluntary Disclosure Program for late filing of the returns and FBARs.  Under the program, the IRS has indicated that it will not impose a penalty for the failure to file delinquent income tax returns if there are no under reported tax liabilities.  On November 30, 2017, the Company received a letter from the IRS concluding their review of the Company's tax returns under the program and accepting the returns as filed.  No penalties have been assessed by the IRS to date, and management does not believe that the Company will incur any penalties relating to the tax years submitted under the program.

 

20 
 

 

 

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Unless the context requires otherwise, references in this document to “ProtoKinetix”, “we”, “our”, “us” or the “Company” are to ProtoKinetix, Incorporated.

 

The following discussion provides information regarding the results of operations for the nine month period ended September 30, 2020 and 2019, and our financial condition, liquidity and capital resources as of September 30, 2020, and December 31, 2019.  The financial statements and the notes thereto contain detailed information that should be referred to in conjunction with this discussion.

 

Cautionary Note Regarding Forward-Looking Statements

The information discussed in this Quarterly Report on Form 10-Q include “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933 (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”).  All statements, other than statements of historical facts, included herein and therein concerning, among other things, planned capital expenditures, future cash flows and borrowings, pursuit of potential acquisition opportunities, our financial position, business strategy and other plans and objectives for future operations, are forward looking statements. These forward looking statements are identified by their use of terms and phrases such as “may,” “expect,” “estimate,” “project,” “plan,” “believe,” “intend,” “achievable,” “anticipate,” “will,” “continue,” “potential,” “should,” “could,” and similar terms and phrases.  Although we believe that the expectations reflected in these forward-looking statements are reasonable, they do involve certain assumptions, risks and uncertainties and are not (and should not considered to be) guarantees of future performance. Our results could differ materially from those anticipated in these forward-looking statements as a result of certain factors, including, among others:

 

  • Our capital requirements and the uncertainty of being able to obtain additional funding on terms acceptable to us;

 

  • Our plans to develop and commercialize products from the AAGP® molecule;

 

  • Ongoing testing of the AAGP® molecule;

 

  • Our intellectual property position;

 

  • Our commercialization, marketing and manufacturing capabilities and strategy;

 

  • Our ability to retain key members of our senior management and key scientific consultants;

 

  • The effects of competition;

 

  • Our potential tax liabilities resulting from conducting business in the United States and Canada;

 

  • The effect of further sales or issuances of our common stock and the price and volume volatility of our common stock; and

 

  • Our common stock’s limited trading history.

 

Finally, our future results will depend upon various other risks and uncertainties, including, but not limited to, those detailed in our filings with the SEC under the Exchange Act and the Securities Act, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2019 and subsequent Quarterly Reports and Current Reports as filed with the SEC.  All forward looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements in this paragraph and elsewhere in this Quarterly Report. Other than as required under securities laws, we do not assume a duty to update these forward-looking statements, whether as a result of new information, subsequent events or circumstances, changes in expectations or otherwise.

 

21 
 

 

 

Business Overview

 

ProtoKinetix, Incorporated is a research and development stage bio-technology company focused on scientific medical research of AFGPs (Anti-Freeze Glycoproteins) or anti-aging glycoproteins, trademarked as AAGP®.  The Company has recently been in the process of directing major efforts to the practical side of commercial validation.  The commercial applications for AAGP® in large markets such as targeted health care solutions are numerous, and ProtoKinetix is currently working with researchers, business leaders and advisors and commercial entities to bring AAGP® to market.

 

In March 2020, the World Health Organization declared coronavirus COVID-19 a global pandemic. This contagious disease outbreak, which has continued to spread, and any related adverse public health developments, has adversely affected workforces, economies, and financial markets globally, potentially leading to an economic downturn.

As of the date of this filing, the Company has regained a significant portion of its operational capacity and we continue to move forward with our research goals. Our supply of the patented AAGP® molecule has been manufactured and stored in the United States and we have adequate inventory to carry out the projects currently underway. The Company engages contract research organizations (CROs) located in both the United States and Canada. The CROs contracted by the Company for research projects have been able to meet milestone goals without disruption due to the pandemic. We cannot predict future disruptions to the Company which may occur due to the spread of COVID-19. We continue to monitor the status of the pandemic and will adjust our strategy accordingly in order to mitigate the impact on our research projects. 

Results of Operations

 

The following table shows selected financial data and operating results for the periods noted.  Following the table, please see management’s discussion of significant changes.

 

    For the Nine Months Ended
    September 30,
    2020   2019
Revenues   $ —       $ —    
Cost of Sales     —         —    
Gross (Loss) Profit     —         —    
Operating Expenses                
Amortization   $ 2,250     $ 2,250  
General and Administrative     174,480       202,238  
Professional Fees     116,112       92,315  
Research and Development     438,544       279,089  
Share-Based Compensation     6,331,290       1,167,629  
Total Operating Expenses     7,062,676       1,743,521  
Loss from Operations     (7,062,676 )     (1,743,521 )
                 
Other Income                
Foreign Exchange Loss     —         (106 )
Total Other Loss     —         (106 )
Net Loss   $ (7,062,676 )     (1,743,627 )

 

 

22 
 

 

 

Revenues

We had no revenues for the nine month periods ended September 30, 2020 and 2019.

 

Gross Profit and Expenses

The Company’s net loss was $7,062,676 for the nine month period ended September 30, 2020 compared to $1,743,627 for the nine month period ended September 30, 2019.  These expenses were primarily incurred for professional fees, consulting services related to the operations of the Company’s business, research and development and other general and administrative expenses.  Significant changes from the prior nine month period ended September 30, 2019 include:

 

General and administrative fees decreased by $27,758 from $202,238 to $174,480 primarily as a result of a decrease in spending on investor relations that overtook the increase in advertising and the upgrade of the company website.

 

Research and development increased significantly with a change of $159,455 from $279,089 to $438,544 with the primary spending being production and testing of AAGP molecule for use in several ongoing research projects including the treatment of macular degeneration and Phase I trials at University of Alberta, Edmonton, Alberta, Canada.

 

Share-based compensation increased significantly by $5,163,661 from $1,167,629 to $6,331,290 as a result of additional stock options granted and vested during the period, as well as the incremental cost associated with replacement stock options granted.

 

Liquidity and Capital Resources

 

The following summarizes our statements of cash flows at September 30, 2020 and December 31, 2019:

 

   

September 30,

2020

  

December 31,

2019

Cash   $ 44,763     $ 377,349  
                 
Working Capital   $ 40,813     $ 352,879  

 

 

At September 30, 2020, we had $44,763 in cash and $45,813 in total current assets.  As of September, 30, 2020, we had a positive working capital equity position of $40,813. Based upon our working capital equity as of September 30, 2020, we will require additional equity and/or debt financing in order to meet cash flow projections and carry forward our business objectives.  

 

There can be no assurance that in the future we will be able to raise capital from outside sources in sufficient amounts to fund our new business. The failure to secure adequate outside funding would have an adverse effect on our plan of operation and results therefrom and a corresponding negative impact on stockholder liquidity.

 

 

23 
 

 

 

Sources and Uses of Cash

 

Net Cash Used in Operating Activities

 

Net cash used in operating activities increased by $92,904 from $656,752 to $749,656 for the nine months ended September 30, 2019 and 2020, respectively.  This increase was predominantly due to an increase in research spending and marketing expense.

 

Net Cash Used in Investing Activities

 

Net cash used in investing activities was $45,380 for the nine month period ended September 30, 2020 while the Company had net cash used in investing activities of $6,418 for the prior year comparative period.  The difference is attributable to an increase in the purchase and maintenance of patents and patent portfolio categorized as intangible assets.

 

Net Cash Provided by Financing Activities

 

Net cash provided by financing activities decreased by $354,550 from $817,000 to $462,450 for the nine months ended September 30, 2019 and 2020, respectively, due to a decrease of funding from private placements which is affected by fluctuations in share price.

 

Going Concern

 

The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”), which contemplate continuation of the Company as a going concern.  The history of losses and the inability for the Company to make a profit from selling a good or service has raised substantial doubt about our ability to continue as a going concern. In spite of the fact that the current cash obligations of the Company are relatively minimal, given the cash position of the Company, we have very little cash to operate. We intend to fund the Company and attempt to meet corporate obligations by selling common stock.  However, the price and volume of the Company’s common stock is volatile.

 

Off-Balance Sheet Arrangements

 

None.

 

Contractual Obligations

 

As a smaller reporting company, we are not required to provide the information required by paragraph (a)(5) of this Item.

 

Critical Accounting Policies

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make a variety of estimates and assumptions that affect (i) the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements, and (ii) the reported amounts of revenues and expenses during the reporting periods covered by the financial statements.

 

Our management routinely makes judgments and estimates about the effect of matters that are inherently uncertain. As the number of variables and assumptions affecting the future resolution of the uncertainties increase, these judgments become even more subjective and complex. Although we believe that our estimates and assumptions are reasonable, actual results may differ significantly from these estimates. Changes in estimates and assumptions based upon actual results may have a material impact on our results of operation and/or financial condition. Our significant accounting policies are disclosed in Note 2 to the Financial Statements included in this Form 10-Q.

 

While all of the significant accounting policies are important to the Company’s financial statements, the following accounting policies and the estimates derived there from have been identified as being critical.

 

 

24 
 

 

 

Share-Based Compensation

 

The Company accounts for stock compensation with persons classified as employees for accounting purposes in accordance with ASC 718 “Compensation – Stock Compensation”, which recognizes awards at fair value on the date of grant and recognition of compensation over the service period for awards expected to vest. Cliff Vesting is used and awards vest on the last day of the vesting period. The fair value of stock options is determined using the Black-Scholes Option Pricing Model. The fair value of common shares issued for services is determined based on the Company’s stock price on the date of issuance.

 

Share-Based Compensation for non-employees in exchange for goods and services used or consumed in an entity’s own operations are also recorded at fair value on the measurement date and accounted for in accordance with ASC 718. The measurement of share-based compensation is subject to periodic adjustment as the underlying instruments vest. The fair value of stock options is estimated using the Black-Scholes Option Pricing Model and the compensation charges are amortized over the vesting period.

 

Sales and Marketing

 

The Company is currently not selling or marketing any products.

 

Inflation

 

Although management expects that our operations will be influenced by general economic conditions, we do not believe that inflation had a material effect on our results of operations during the nine months ended September 30, 2020.

 

Item 3. Quantitative and Qualitative Disclosure About Market Risk

 

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, we are not required to provide information required by this Item.

 

Item 4: Controls and Procedures

 

Disclosure Controls and Procedures

 

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934 (the “1934 Act”) is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed under the 1934 Act is accumulated and communicated to management, including our principal executive officer and our principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

 

Our management, under the direction of our Chief Executive Officer (who is our principal executive officer), and Chief Financial Officer (who is our principal accounting officer) has evaluated the effectiveness of our disclosure controls and procedures as required by 1934 Act Rule 13a-15(b) as of June 30, 2020 (the end of the period covered by this report).  Based on that evaluation, our principal executive officer and our principal accounting officer concluded that these disclosure controls and procedures are effective to provide reasonable assurance that information required to be disclosed by the Company in the reports that it files or submits under the 1934 Act is accumulated and communicated to management, including the Chief Executive Officer and the Chief Financial Officer, to allow timely decisions regarding required disclosure and are effective to provide reasonable assurance that such information is recorded, processed, summarized and reported within the time periods specified by the SEC’s rules and forms.

 

The Company, including its Chief Executive Officer and Chief Financial Officer, does not expect that its internal controls and procedures will prevent or detect all error and all fraud. A control system, no matter how well conceived or operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met.

 

Internal Control Over Financial Reporting

 

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) promulgated by the SEC under the 1934 Act) during the six months ended June 30, 2020, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

25 
 

 

 

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings

 

Other than previously reported, the Company and its management are not aware of any regulatory or legal proceedings or investigations pending involving the Company, any of its subsidiaries or affiliates, or any of their respective officers, directors or employees.

 

Item 1A. Risk Factors

 

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, we are not required to provide information required by this Item.  However, our current risk factors are set forth in our Annual Report on Form 10-K for the year ended December 31, 2019 as filed with the SEC on February 19, 2020, in our Current Report on Form 8-K as filed with the SEC on March 31, 2020, and such risk factors are incorporated herein by this reference and below.

 

We face significant business disruption and related risks resulting from the COVID-19 pandemic, which could have a material adverse effect on our business and results of operations. 

 

The ongoing and developing COVID-19 pandemic has caused a broad impact globally. While the potential economic impact brought by, and the duration of, the COVID-19 pandemic is difficult to assess or predict, any resulting recession or economic slowdown will have a negative impact on our business and results of operations.

 

As of the date of this filing, the Company has regained a significant portion of its operational capacity and we continue to move forward with our research goals. Our supply of the patented AAGP® molecule has been manufactured and stored in the United States and we have adequate inventory to carry out the projects currently underway. The Company engages contract research organizations (CROs) located in both the United States and Canada. The CROs contracted by the Company for research projects have been able to meet milestone goals without disruption due to the pandemic. We cannot predict future disruptions to the Company which may occur due to the spread of COVID-19. We continue to monitor the status of the pandemic and will adjust our strategy accordingly in order to mitigate the impact on our research projects.

 

In addition, any significant disruption of global financial markets, reducing our ability to access capital, could negatively affect our liquidity and ability to continue operations. The exact impact is and will remain unknown and largely dependent upon future developments, including but not limited to information on the duration and spread of COVID-19, changes in customer demand, additional mitigation strategies proposed by governmental authorities (including federal, state, or local stay at home or similar orders), restrictions on the activities of our domestic and international suppliers and shipment of goods.

 

 

26 
 

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

Between April 13, 2020 and May 29, 2020, the Company sold 2,222,222 shares of common stock of the Company at a price per share of $0.09 for gross proceeds of $200,000 to accredited investors in a private placement, of which the Company’s President and CEO purchased 222,222 shares for gross proceeds of $20,000. No solicitation was used in the offering. The Company relied on the exemption from registration available under Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated under the Securities Act with respect to transactions by an issuer not involving any public offering.  No commissions were paid in connection with these issuances of securities.  A Form D was filed on April 24, 2020 and an amended Form D was filed on June 2, 2020.

Between July 20, 2020 and July 27, 2020, the Company sold 320,513 shares of common stock at a price per share of $0.078 for gross proceeds of $25,000 to accredited investors in a private placement. No solicitation was used in the offering. The Company relied on the exemption from registration available under Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated under the Securities Act with respect to transactions by an issuer not involving any public offering.  No commissions were paid in connection with these issuances of securities.  A Form D was filed on August 4, 2020.

Between August 4, 2020 and September 9, 2020, the Company sold 3,653,077 shares of common stock of the Company at a price per share of $0.065 for gross proceeds of $237,450 to accredited investors in a private placement, of which the Company’s President and CEO purchased 1,000,000 shares for gross proceeds of $65,000. No solicitation was used in the offering. The Company relied on the exemption from registration available under Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated under the Securities Act with respect to transactions by an issuer not involving any public offering.  No commissions were paid in connection with these issuances of securities.  A Form D was filed on August 13, 2020 and an amended Form D was filed on September 1, 2020.

Other than described herein, there have been no other unregistered sales of equity securities during the nine month period ended September 30, 2020.

 

Item 3. Defaults upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosure

 

Not applicable.

 

Item 5. Other Information

 

None.

 

27 
 

 

 

Item 6. Exhibits

 

The following is a complete list of exhibits filed as part of this Form 10-Q.  Exhibit numbers correspond to the numbers in the Exhibit Table of Item 601 of Regulation S-K.

 

EXHIBIT INDEX

 

The following documents are being filed with the Commission as exhibits to this Quarterly Report on Form 10-Q.

 

Exhibit   Description
3.1   Articles of Incorporation as filed on December 23, 1999(1)
3.2   Articles of Amendment to Articles of Incorporation as filed on July 8, 2003(11)
3.3   Articles of Amendment to Articles of Incorporation as filed on December 8, 2003(11)
3.4   Certificate of Change to the Articles of Incorporation as filed November 16, 2011(11)
3.5   Certificate of Change to the Articles of Incorporation as filed May 1, 2014(11)
3.6   Bylaws(1)
4.1   Amended 2017 Stock Option and Stock Bonus Plan(2)
4.2   Amendment to Amended 2017 Stock Option and Stock Bonus Plan as approved on July 15, 2019(5)
4.3   Amendment to Amended 2017 Stock Option and Stock Bonus Plan as approved on April 6, 2020(9)
10.1   Royalty Agreement between the Company and The Governors of the University of Alberta, dated April 8, 2015(3)
10.2   Collaborative Research Agreement between the Company and the University of British Columbia, dated May 31, 2016(4)
10.3   Consulting Agreement between the Company and Clarence E. Smith, dated December 30, 2016(6)
10.4   Director Consulting Agreement between the Company and Edward P. McDonough, dated December 30, 2016(6)
10.5   Consulting Agreement between the Company and Grant Young, dated December 30, 2016(7)
10.6   First Amendment to Consulting Agreement between Clarence E. Smith and the Company dated September 1, 2017(8)
10.7   First Amendment to Consulting Agreement between Grant Young and the Company dated September 1, 2017(8)
10.8   First Amendment to Consulting Agreement between Edward P. McDonough and the Company dated September 1, 2017(8)
10.9   Consulting Agreement between ProtoKinetix Incorporated and Michael Guzzetta, dated November 14, 2017(10)
31.1   Certification of the Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
31.2   Certification of the Principal Financial Officer and Principal Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
32.1   Certification of the Principal Executive Officer and the Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**
101.INS   XBRL Instance Document
101.SCH   XBRL Schema Document 
101.CAL   XBRL Calculation Linkbase Document 
101.DEF   XBRL Definition Linkbase Document 
101.LAB   XBRL Label Linkbase Document
101.PRE   XBRL Presentation Linkbase Document  

 

  1. Incorporated by reference from the Company’s registration statement on Form 10-SB filed on June 22, 2001 with the SEC.

 

  2. Incorporated by reference from the Company’s Current Report on Form 8-K filed on November 13, 2018 with the SEC.

 

  3. Incorporated by reference from the Company’s Annual Report on Form 10-K filed on April 14, 2015 with the SEC.

 

  4. Incorporated by reference from the Company’s Quarterly Report on Form 10-Q filed on August 15, 2016 with the SEC.

 

  5. Incorporated by reference from the Company’s Current Report on Form 8-K filed on July 17, 2019 with the SEC.

 

  6. Incorporated by reference from the Company’s Annual Report on Form 10-K filed on February 21, 2017 with the SEC.

 

  7. Incorporated by reference from the Company’s Quarterly Report on Form 10-Q filed on November 13, 2017 with the SEC.

 

  8. Incorporated by reference from the Company’s amended Current Report on Form 8-K filed on September 12, 2017 with the SEC.

 

  9. Incorporated by reference from the Company’s Current Report on Form 8-K filed on April 10, 2020 with the SEC.

 

  10. Incorporated by reference from the Company’s Current Report on Form 8-K filed on November 15, 2017 with the SEC.

 

  11.

Incorporated by reference from the Company’s Quarterly Report on Form 10-Q filed on July 10, 2020 with the SEC.

 

  * Filed herewith.

 

  ** Furnished, not filed herewith.

 

 

28 
 

 

 SIGNATURES

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: October 16, 2020   PROTOKINETIX, INCORPORATED
     
    By: /s/ Clarence E. Smith
    Clarence E. Smith
    Chief Executive Officer
     
    By: /s/ Michael Guzzetta
    Michael Guzzetta
    Chief Financial Officer

 

 

 

 

29 
 

 EX-31.1 2 ex31x1.htm EXHIBIT 31.1

 

 

EXHIBIT 31.1

 

 

CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Clarence E. Smith, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q of ProtoKinetix, Incorporated for the period ended September 30, 2020;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

October 16, 2020   /s/ Clarence E. Smith
    Name: Clarence E. Smith
    Title:

Chief Executive Officer

(Principal Executive Officer)

 

 EX-31.2 3 ex31x2.htm EXHIBIT 31.2

 

 

EXHIBIT 31.2

 

 

CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Michael R. Guzzetta, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q of ProtoKinetix, Incorporated for the period ended September 30, 2020;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

October 16, 2020   /s/ Michael R. Guzzetta
    Name: Michael R. Guzzetta
    Title:

Chief Financial Officer

(Principal Financial Officer)

 

 

 EX-32 4 ex32.htm EXHIBIT 32

 

 

 

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of ProtoKinetix, Incorporated, (the “Company”) on Form 10-Q for the period ended September 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Clarence E. Smith, Chief Executive Officer and Principal Executive Officer of the Company and Michael R. Guzzetta, Chief Financial Officer and Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of the undersigned’s knowledge and belief:

 

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.

 

October 16, 2020   /s/ Clarence E. Smith
    Name: Clarence E. Smith
    Title:

Chairman of the Board and
Chief Executive Officer

(Principal Executive Officer)

 

October 16, 2020   /s/ Michael R. Guzzetta
    Name: Michael R. Guzzetta
    Title:

Chief Financial Officer

(Principal Financial Officer)

 

 

This certification accompanies this Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

 

 EX-101.INS 5 pktx-20200930.xml XBRL INSTANCE FILE 0001128189 2020-01-01 2020-09-30 0001128189 2019-12-31 0001128189 2020-09-30 0001128189 us-gaap:PatentsMember 2019-12-31 0001128189 us-gaap:PatentsMember 2020-09-30 0001128189 pktx:PatentApplicationRightsMember 2019-12-31 0001128189 pktx:PatentApplicationRightsMember 2020-09-30 0001128189 2018-12-31 0001128189 2019-09-30 0001128189 2019-01-01 2019-09-30 0001128189 srt:ChiefFinancialOfficerMember 2020-01-01 2020-09-30 0001128189 us-gaap:WarrantMember 2020-01-01 2020-09-30 0001128189 us-gaap:StockOptionMember 2020-01-01 2020-09-30 0001128189 us-gaap:WarrantMember 2019-01-01 2019-09-30 0001128189 us-gaap:StockOptionMember 2019-01-01 2019-09-30 0001128189 us-gaap:PatentsMember 2018-12-31 0001128189 pktx:PatentApplicationRightsMember 2018-12-31 0001128189 us-gaap:PatentsMember 2020-01-01 2020-09-30 0001128189 pktx:PatentApplicationRightsMember 2020-01-01 2020-09-30 0001128189 us-gaap:PatentsMember 2019-01-01 2019-12-31 0001128189 pktx:PatentApplicationRightsMember 2019-01-01 2019-12-31 0001128189 2019-01-01 2019-12-31 0001128189 pktx:PatentApplicationRightsMember 2016-01-01 2016-12-31 0001128189 us-gaap:StockOptionMember 2019-12-31 0001128189 us-gaap:StockOptionMember 2020-09-30 0001128189 pktx:WarrantOneMember 2020-09-30 0001128189 pktx:WarrantOneMember 2020-01-01 2020-09-30 0001128189 pktx:InvestorsMember 2019-01-01 2019-09-30 0001128189 pktx:InvestorsMember 2019-09-30 0001128189 srt:ChiefFinancialOfficerMember 2019-01-01 2019-09-30 0001128189 pktx:ClarenceSmithCEOMember 2020-01-01 2020-09-30 0001128189 pktx:WarrantTwoMember 2020-01-01 2020-09-30 0001128189 pktx:WarrantThreeMember 2020-01-01 2020-09-30 0001128189 pktx:WarrantFourMember 2020-01-01 2020-09-30 0001128189 pktx:WarrantFiveMember 2020-01-01 2020-09-30 0001128189 pktx:WarrantSixMember 2020-01-01 2020-09-30 0001128189 pktx:WarrantSevenMember 2020-01-01 2020-09-30 0001128189 pktx:WarrantEightMember 2020-01-01 2020-09-30 0001128189 pktx:WarrantTwoMember 2020-09-30 0001128189 pktx:WarrantThreeMember 2020-09-30 0001128189 pktx:WarrantFourMember 2020-09-30 0001128189 pktx:WarrantFiveMember 2020-09-30 0001128189 pktx:WarrantSixMember 2020-09-30 0001128189 pktx:WarrantSevenMember 2020-09-30 0001128189 pktx:WarrantEightMember 2020-09-30 0001128189 pktx:Date1Member 2020-09-30 0001128189 pktx:Date2Member 2020-09-30 0001128189 pktx:Date3Member 2020-09-30 0001128189 pktx:Date4Member 2020-09-30 0001128189 pktx:Date5Member 2020-09-30 0001128189 pktx:Date6Member 2020-09-30 0001128189 pktx:Date7Member 2020-09-30 0001128189 pktx:Date8Member 2020-09-30 0001128189 pktx:Date9Member 2020-09-30 0001128189 us-gaap:StockOptionMember 2018-12-31 0001128189 us-gaap:StockOptionMember 2019-09-30 0001128189 2020-07-01 2020-09-30 0001128189 2019-07-01 2019-09-30 0001128189 pktx:Date10Member 2020-09-30 0001128189 pktx:Date11Member 2020-09-30 0001128189 pktx:ResearchAndDevelopmentMember 2020-05-06 0001128189 pktx:InvestorsMember 2020-01-01 2020-09-30 0001128189 pktx:InvestorsMember 2020-09-30 0001128189 pktx:Investors1Member 2019-01-01 2019-09-30 0001128189 pktx:Investors1Member 2019-09-30 0001128189 pktx:Investors2Member 2019-01-01 2019-09-30 0001128189 pktx:Investors2Member 2019-09-30 0001128189 pktx:ClarenceSmithCEOMember 2020-01-01 2020-03-25 0001128189 2020-01-01 2020-03-25 0001128189 pktx:InvestorsOneMember 2020-01-01 2020-09-30 0001128189 pktx:Investors2Member 2020-01-01 2020-09-30 0001128189 pktx:Investors1Member 2020-09-30 0001128189 pktx:Investors2Member 2020-09-30 0001128189 2020-03-26 0001128189 2020-06-12 0001128189 2020-10-16 0001128189 us-gaap:CommonStockMember 2020-01-01 2020-09-30 0001128189 us-gaap:CommonStockMember 2019-01-01 2019-09-30 0001128189 us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001128189 us-gaap:CommonStockMember 2019-07-01 2019-09-30 0001128189 us-gaap:CommonStockMember 2019-12-31 0001128189 us-gaap:CommonStockMember 2020-09-30 0001128189 us-gaap:CommonStockMember 2018-12-31 0001128189 us-gaap:CommonStockMember 2019-09-30 0001128189 us-gaap:CommonStockMember 2020-06-30 0001128189 us-gaap:CommonStockMember 2019-06-30 0001128189 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-09-30 0001128189 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-09-30 0001128189 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001128189 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0001128189 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001128189 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001128189 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001128189 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0001128189 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001128189 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001128189 us-gaap:RetainedEarningsMember 2020-01-01 2020-09-30 0001128189 us-gaap:RetainedEarningsMember 2019-01-01 2019-09-30 0001128189 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001128189 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0001128189 us-gaap:RetainedEarningsMember 2019-12-31 0001128189 us-gaap:RetainedEarningsMember 2020-09-30 0001128189 us-gaap:RetainedEarningsMember 2018-12-31 0001128189 us-gaap:RetainedEarningsMember 2019-09-30 0001128189 us-gaap:RetainedEarningsMember 2020-06-30 0001128189 us-gaap:RetainedEarningsMember 2019-06-30 0001128189 2020-06-30 0001128189 2019-06-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure --12-31 2020-09-30 Non-accelerated Filer 10-Q false 2020 ProtoKinetix, Inc. 0001128189 Yes true false 000-32917 false Yes 0.0000053 0.0000053 400000000 400000000 NV 275400259 281596071 275400259 281596071 8500000 83100000 6000000 76450000 45380 2415 83100000 91450000 83100000 1200000 750000 800000 600000 15000000 1600000 18500000 15000000 22000000 58600000 76450000 650000 7000000 0.14 0.15 0.05 0.07 0.06 0.08 0.09 0.13 0.26 0.11 0.14 .07 0.15 0.11 0.12 0.0176 0.0255 0.0241 0.0176 0.0176 0.0081 0.0000 0.00 0.00 0.0000 0.0000 0.0000 1.4475 1.4357 1.25 1.4475 1.4440 1.4440 0.00 0.00 0.00 0.00 0.00 0.00 P6Y P5Y1M2D P4Y7M6D P6Y P6Y P6Y 83100000 650000 1005350 458165 8500000 8500000 6000000 6000000 0.22 0.22 0.26 0.26 0.26 0.12 0.12 0.12 0.12 0.12 0.12 0.12 8500000 6000000 833333 250000 116667 83334 833333 166667 216666 July 14, 2024 October 15, 2022 October 21, 2022 November 11, 2022 November 12, 2022 December 1 , 2022 December 18, 2022 December 18, 2022 0 0 750000 97826 2222222 10000000 2266667 320513 3653077 0.06 0.09 0.05 0.12 0.078 0.065 45000 200000 500000 272000 25000 237450 502795 335197 5704 282844 45000 45000 9450 9450 0 0 79187500 1200000 750000 800000 600000 15000000 1600000 18500000 11250000 22000000 487500 7000000 22000000 7000000 29650000 34100000 29650000 34100000 2000000 0.13 0.25 0.04 P4Y2M23D P3Y5M23D 221008 266388 30000 30000 191008 236388 198271 30000 168271 45380 0 45380 0 22737 22737 13500 15750 13500 15750 0 0 10500 10500 0 2250 2250 0 3000 0 3000 207508 250638 191008 14250 16500 236388 1050 1050 281596071 36000000 16000000 0.13 0.07 Options are exercisable at $0.11 per share for a period of six years and expire on May 5, 2026 235703 Q3 0.12 0.07 250000 250000 0.07 585907 296451 -35548143 -42610819 36107058 42900764 1472 1506 25520 5000 25520 5000 585907 296451 378399 45813 1050 1050 277211051 267232714 279648342 272816256 -0.03 -0.01 -0.01 -0.00 -7062676 -1743627 -1687484 -591928 0 -106 -90 7062676 1743521 1687484 591838 6331290 1167629 1458990 342218 438544 279089 142221 140933 116112 92315 39063 31032 174480 202238 46460 76905 2250 2250 750 750 0 0 0 0 377349 44763 136029 289859 -332586 153830 462450 817000 462450 817000 -45380 -6418 45380 6418 -749656 -656752 -20520 -73464 0 9540 <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt"><b>Note 1.&#160; Basis of Presentation &#8211; Going Concern Uncertainties</b></font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">ProtoKinetix, Incorporated (the &#8220;Company&#8221;), a development stage company, was incorporated under the laws of the State of Nevada on December 23, 1999.&#160; The Company is a medical research company whose mission is the advancement of human health care.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">The Company is currently researching the benefits and feasibility of synthesized Antifreeze Glycoproteins (&#8220;AFGP&#8221;) or anti-aging glycoproteins, trademarked AAGP.&#160; During the year ended December 31, 2015, the Company acquired certain patents and rights for cash consideration of $30,000 (25,000 Euros), as well as additional patent applications for cash consideration of $10,000 and 6,000,000 share purchase warrants with a fair value of $25,000 (Note 4).</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">The Company&#8217;s financial statements are prepared consistent with accounting principles generally accepted in the United States applicable to a going concern.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">The Company has not developed a commercially viable product, has not generated any significant revenue to date, and has incurred losses since inception, resulting in a net accumulated deficit at September 30, 2020.&#160; These factors raise substantial doubt about the Company&#8217;s ability to continue as a going concern.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">The Company needs additional working capital to continue its medical research or to be successful in any future business activities and continue to pay its liabilities.&#160; Therefore, continuation of the Company as a going concern is dependent upon obtaining the additional working capital necessary to accomplish its objective.&#160; Management is presently engaged in seeking additional working capital through equity financing or related party loans.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0.1pt; text-align: justify"><font style="font-size: 10pt">In March 2020, the World Health Organization declared coronavirus COVID-19 a global pandemic. This contagious disease outbreak, which has continued to spread, and any related adverse public health developments, has adversely affected workforces, economies, and financial markets globally, potentially leading to an economic downturn. It is not possible for the Company to predict the duration or magnitude of the adverse results of the outbreak and its effects on the Company&#8217;s business or ability to raise funds.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">The accompanying financial statements do not include any adjustments to the recorded assets or liabilities that might be necessary should the Company fail in any of the above objectives and is unable to operate for the coming year.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt"><b>Note 2. Summary of Significant Accounting Policies</b></font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt"><b><u>Basis of Presentation</u></b></font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">The accompanying unaudited financial statements have been prepared by the Company in conformity with accounting principles generally accepted in the United States of America (&#8220;US GAAP&#8221;) applicable to interim financial information and with the rules and regulations of the United States Securities and Exchange Commission. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed, or omitted, pursuant to such rules and regulations. In the opinion of management, the unaudited interim financial statements include all adjustments necessary for the fair presentation of the results of the interim periods presented. All adjustments are of a normal recurring nature, except as otherwise noted below. These financial statements should be read in conjunction with the Company&#8217;s audited financial statements and notes thereto for the year ended December 31, 2019, included in the Company&#8217;s Annual Report on Form 10-K, filed February 19, 2020, with the Securities and Exchange Commission. The results of operations for the interim periods are not necessarily indicative of the results of operations for any other interim period or for a full fiscal year.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt"><b><u>Use of Estimates</u></b></font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">Preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period.&#160; Actual results could differ from those estimates.&#160; The more significant accounting estimates inherent in the preparation of the Company&#8217;s financial statements include estimates as to valuation of equity related instruments issued, deferred income taxes, and the useful life and impairment of intangible assets.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt"><b><u>Cash</u></b></font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">Cash consists of funds held in checking accounts.&#160; Cash balances may exceed federally insured limits from time to time.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt"><b><u>Fair Value of Financial Instruments</u></b></font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">Financial instruments, which includes cash and accounts payable and accrued liabilities, are carried at cost, which management believes approximates fair value due to the short-term nature of these instruments.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">The Company measures the fair value of financial assets and liabilities pursuant to ASC 820 &#8220;Fair Value Measurements and Disclosures&#8221; which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. ASC 820 establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The policy describes three levels of inputs that may be used to measure fair value:</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">Level 1 &#8211; quoted prices in active markets for identical assets or liabilities</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">Level 2 &#8211; quoted prices for similar assets and liabilities in active markets or inputs that are observable</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">Level 3 &#8211; inputs that are unobservable (for example cash flow modeling inputs based on assumptions)</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">Level 1 inputs are used to measure cash. At September 30, 2020, there were no other assets or liabilities subject to additional disclosure.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt"><b><u>Income Taxes</u></b></font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">The Company accounts for income taxes following the assets and liability method in accordance with the ASC 740 &#8220;Income Taxes.&#8221;&#160; Under such method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases.&#160; The Company applies the accounting guidance issued to address the accounting for uncertain tax positions.&#160; This guidance clarifies the accounting for income taxes, by prescribing a minimum recognition threshold a tax position is required to meet before being recognized in the financial statements as well as provides guidance on derecognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition.&#160; Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years that the asset is expected to be recovered or the liability settled.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt"><b><u>Intangible assets &#8211; patent and patent application costs</u></b></font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">The Company owns intangible assets consisting of certain patents and patent applications. Intangible assets acquired separately are measured on initial recognition at cost. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and any accumulated impairment losses. Subsequent expenditures are capitalized only when they increase the future economic benefits embodied in the specific asset to which they relate. All other expenditures are recognized in profit or loss as incurred.</font></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">As at September 30, 2020, the Company does not hold any intangible assets with indefinite lives.</font></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">Intangible assets with finite lives are amortized over the useful economic life and assessed for impairment whenever there is an indication that the intangible asset may be impaired. The amortization method and amortization period of an intangible asset with a finite life is reviewed at least annually.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset is accounted for by changing the amortization period or method, as appropriate, and are treated as changes in accounting estimates. Amortization is recognized in profit or loss on a straight-line basis over the estimated useful lives of the Company&#8217;s patents. No amortization is recognized on patent application costs, as amortization of these costs will only commence once the patents have been granted.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt"><b><u>Research and Development Costs</u></b></font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">Research and development costs are expensed as incurred.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt"><b><u>Loss per Share and Potentially Dilutive Securities</u></b></font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">Basic loss per share is computed by dividing the net loss available to common stockholders by the weighted average number of common shares outstanding in the period.&#160; Diluted loss per share takes into consideration common shares outstanding (computed under basic earnings per share) and potentially dilutive securities.&#160; The effect of 83,100,000 stock options (September 30, 2019 &#8211; 76,450,000), and 8,500,000 warrants (September 30, 2019 &#8211; 6,000,000) were not included in the computation of diluted earnings per share for all periods presented because it was anti-dilutive due to the Company&#8217;s losses.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt"><b><u>Share-Based Compensation</u></b></font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">The Company has granted warrants and options to purchase shares of the Company&#8217;s common stock to various parties for consulting services.&#160; The fair values of the warrants and options issued have been estimated using the Black-Scholes Option Pricing Model.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">The Company accounts for stock compensation with persons classified as employees for accounting purposes in accordance with ASC 718 &#8220;Compensation &#8211; Stock Compensation&#8221;, which recognizes awards at fair value on the date of grant and recognition of compensation over the service period for awards expected to vest. Cliff Vesting is used and awards vest on the last day of the vesting period. The fair value of stock options is determined using the Black-Scholes Option Pricing Model. The fair value of common shares issued for services is determined based on the Company&#8217;s stock price on the date of issuance.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">Share-based compensation for non-employees in exchange for goods and services used or consumed in an entity&#8217;s own operations are also recorded at fair value on the measurement date and accounted for in accordance with ASC 718. The measurement of share-based compensation is subject to periodic adjustment as the underlying instruments vest. The fair value of stock options is estimated using the Black-Scholes Option Pricing Model and the compensation charges are amortized over the vesting period.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt"><b><u>Common stock</u></b></font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">Common stock issued for non-monetary consideration are recorded at their fair value on the measurement date and classified as equity. The measurement date is defined as the earliest of the date at which the commitment for performance by the counterparty to earn the common shares is reached or the date at which the counterparty&#8217;s performance is complete.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">Transaction costs directly attributable to the issuance of common stock, units and stock options are recognized as a deduction from equity, net of any tax effects.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt"><b><u>Related Party Transactions</u></b></font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">A related party is generally defined as (i) any person that holds 10% or more of the Company&#8217;s securities and their immediate families, (ii) the Company&#8217;s management, (iii) someone that directly or indirectly controls, is controlled by or is under common control with the Company, or (iv) anyone who can significantly influence the financial and operating decisions of the Company.&#160; A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt"><b><u>Recent Accounting Pronouncements</u></b></font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0.1pt"><font style="font-size: 10pt">Certain new accounting pronouncements that have been issued are not expected to have a material effect on the Company&#8217;s financial statements.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt"><b>Note 3.&#160;&#160; Prepaid Expenses</b></font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt"><b>&#160;</b></font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">The following summarizes the Company&#8217;s prepaid expenses outstanding as at September 30, 2020 and December 31, 2019:</font></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>September 30, <br /> &#160;2020</b></font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, <br /> &#160; 2019</b></font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td colspan="3"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td colspan="3"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 66%; padding-bottom: 1pt; text-align: justify"><font style="font-size: 10pt">Rental deposit</font></td> <td style="width: 1%; padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; width: 1%; padding-bottom: 1pt"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1pt solid; width: 14%; padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">1,050</font></td> <td style="width: 1%; padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%; padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; width: 1%"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1pt solid; width: 14%; text-align: right"><font style="font-size: 10pt">1,050</font></td> <td style="width: 1%; padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">1,050</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,050</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt"><b>Note 4.&#160; &#160;Intangible Assets</b></font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt"><b>&#160;</b></font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">Intangible asset transactions are summarized as follows:</font></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0.1pt 0.1pt; text-align: justify"><font style="font-size: 10pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Patent Rights</b></font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Patent Application Rights</b></font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Total</b></font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt"><b>Cost</b></font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 55%; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Balance, December 31, 2018</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 12%; text-align: right"><font style="font-size: 10pt">30,000</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 12%; text-align: right"><font style="font-size: 10pt">168,271</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 12%; text-align: right"><font style="font-size: 10pt">198,271</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Additions</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">22,737</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">22,737</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Balance, December 31, 2019</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">30,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">191,008</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">221,008</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Additions</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">45,380</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">45,380</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Balance, September 30, 2020</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 5.4pt"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">30,000</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 5.4pt"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">236,388</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">266,388</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt"><b>Accumulated amortization</b></font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Balance, December 31, 2018</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">10,500</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">10,500</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Amortization</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">3,000</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">3,000</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Balance, December 31, 2019</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">13,500</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">13,500</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Amortization</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">2,250</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">2,250</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Balance,September 30, 2020</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 5.4pt"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">15,750</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 5.4pt"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">15,750</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt"><b>Net carrying amounts</b></font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">December 31, 2019</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">16,500</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">191,008</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">207,508</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">September 30, 2020</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 5.4pt"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">14,250</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 5.4pt"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">236,388</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">250,638</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0.1pt; text-align: justify"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">During the year ended December 31, 2015, the Company entered into an Assignment of Patents and Patent Application (effective January 1, 2015) (the &#8220;Patent Assignment&#8221;) with the Institut National des Sciences Appliquees de Rouen (&#8220;INSA&#8221;) for the assignment of certain patents and all rights associated therewith (the &#8220;Patents&#8221;). The Company and INSA had previously entered into a licensing agreement for the Patents in August 2004. The Patent Assignment transfers all of the Patents and rights associated therewith to the Company, upon payment to INSA in the sum of $30,000. During the nine month period ended September 30, 2020, the Company recorded $2,250 (2019 - $2,250) in amortization expense associated with the Patents.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">During the year ended December 31, 2015, the Company entered into a Technology Transfer Agreement with Grant Young for the assignment of his 50% ownership of certain patents and all rights associated therewith (the &#8220;Patent Application Rights&#8221;).&#160; In exchange for the Patent Application Rights, the Company agreed to pay $10,000 (paid) and to issue 6,000,000 warrants (issued) to purchase shares of the Company&#8217;s common stock at an exercise price of $0.10 per share for a period of five years. The Patent Application Rights had a total fair value of $35,000, which was allocated as $10,000 to the cash consideration paid, with the remaining $25,000 being allocated to the warrant component of the overall consideration. The Company has incurred $201,388 in direct costs relating to the Patent Application Rights, $45,380 of which were incurred during the nine month period ended September 30, 2020.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">The remaining 50% ownership of the Patent Application Rights was acquired from the Governors of the University of Alberta in exchange for a future gross revenue royalty.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">During the year ended December 31, 2016, the Company entered into a Universal Assignment with Grant Young for the assignment of his ownership of certain new and useful improvements in an invention entitled &#8220;Use of Anti-Aging Glycoprotein for Enhancing Survival of Neurosensory Precursor Cells&#8221; (the &#8220;New Patent Application Rights&#8221;).&#160; In exchange for the New Patent Application Rights, the Company agreed to pay $1 (paid).&#160; The Company incurred $2,415 in direct costs relating to the New Patent Application Rights during the year ended December 31, 2016.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">No amortization was recorded on the Patent Application Rights to September 30, 2020.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt"><b>Note 5.&#160; Stock Options</b></font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 5pt 0.1pt; text-align: justify"><font style="font-size: 10pt">Pursuant to an amendment on April 6, 2020, the aggregate number of shares that may be issued under the 2017 Stock Option and Stock Bonus Plan (the &#8220;2017 Plan&#8221;) is 85,700,000 shares, subject to adjustment as provided therein. The 2017 Plan is administered by the Company&#8217;s Board of Directors, or a committee appointed by the Board of Directors, and includes two types of options. Options intended to qualify as incentive stock options under Section 422 of the Internal Revenue Code of 1986, as amended, are referred to as incentive options. Options that are not intended to qualify as incentive options are referred to as non-qualified options. The exercise price of an option may be paid in cash, in shares of the Company's common stock or other property having a fair market value equal to the exercise price of the option, or in a combination of cash, shares, other securities and property.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 5pt 0.1pt; text-align: justify"><font style="font-size: 10pt">As of September 30, 2020, there are 83,100,000 options granted and outstanding under the 2017 Plan.</font></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">Stock option transactions are summarized as follows:</font></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt; text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of Stock Options</b></font></td> <td style="padding-bottom: 1pt; text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Exercise Price</b></font></td> <td style="padding-bottom: 1pt; text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Remaining Life</b></font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="padding-bottom: 1pt; text-align: center"><font style="font-size: 10pt"><b>$</b></font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="padding-bottom: 1pt; text-align: center"><font style="font-size: 10pt"><b>(Years)</b></font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 46%; padding-left: 5.4pt"><font style="font-size: 10pt">Outstanding, December 31, 2019</font></td> <td style="width: 5%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">91,450,000</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 5%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">0.14</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 5%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;Options cancelled</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">(36,000,000</font></td> <td><font style="font-size: 10pt">)</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.13</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;Options expired</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">(2,000,000</font></td> <td><font style="font-size: 10pt">)</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.04</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;Options granted</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">29,650,000</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">0.13</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-left: 15.3pt; text-indent: -15.3pt"><font style="font-size: 10pt">Outstanding, September 30, 2020</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 15.3pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 15.3pt; text-align: right"><font style="font-size: 10pt">83,100,000</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 15.3pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 15.3pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 15.3pt; text-align: right"><font style="font-size: 10pt">0.15</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 15.3pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 15.3pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">4.23</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt; text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of Stock Options</b></font></td> <td style="padding-bottom: 1pt; text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Exercise Price</b></font></td> <td style="padding-bottom: 1pt; text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Remaining Life</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt; text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="padding-bottom: 1pt; text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt; text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="padding-bottom: 1pt; text-align: center"><font style="font-size: 10pt"><b>$</b></font></td> <td style="padding-bottom: 1pt; text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="padding-bottom: 1pt; text-align: center"><font style="font-size: 10pt"><b>(Years)</b></font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 48%; padding-left: 5.4pt"><font style="font-size: 10pt">Outstanding, December 31, 2018</font></td> <td style="width: 3%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">58,600,000</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 5%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">0.07</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 5%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;Options cancelled</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">(16,000,000</font></td> <td><font style="font-size: 10pt">)</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.07</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;Options exercised</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">(250,000</font></td> <td><font style="font-size: 10pt">)&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.07</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;Options granted</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">34,100,000</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">0.25</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-left: 15.3pt; text-indent: -15.3pt"><font style="font-size: 10pt">Outstanding, September 30, 2019</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 15.3pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 15.3pt; text-align: right"><font style="font-size: 10pt">76,450,000</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 15.3pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 15.3pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 15.3pt; text-align: right"><font style="font-size: 10pt">0.15</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 15.3pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 15.3pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">3.48</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 5pt 0.2pt 0; text-align: justify"><font style="font-size: 10pt">On May 6, 2020, the Company granted 650,000 stock options to a research and development, and a business development consultant of the Company. The options are exercisable at $0.11 per share for a period of six years and expire on May 5, 2026. The options vest in equal instalments starting on the date of grant with the remaining options vesting on a quarterly basis beginning on June 30, 2020.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 5pt 0.2pt 0; text-align: justify"><font style="font-size: 10pt">The Company granted 22,000,000 replacement options and 7,000,000 replacement options on March 26, 2020 and June 12, 2020, respectively, to certain key management (Note 8) and a consultant (Note 9) of the Company. Total share-based compensation for 29,650,000 stock options granted (2019 - 34,100,000) and vested during the nine month period ended September 30, 2020 was $6,331,290 (2019 - $1,167,629) at a weighted average fair value per option of $0.12 (2019 - $0.07). The fair values of the stock options granted were estimated using the Black-Scholes Option Pricing Model, based on the following weighted average assumptions:</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 5pt 0.2pt 0; text-align: justify"><font style="font-size: 10pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>September 30, 2020</b></font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>September 30, 2019</b></font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 68%; text-indent: 0.5in"><font style="font-size: 10pt">Risk-free interest rate</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 13%; text-align: right"><font style="font-size: 10pt">2.55</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 13%; text-align: right"><font style="font-size: 10pt">2.41</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-indent: 0.5in"><font style="font-size: 10pt">Dividend yield</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.00</font></td> <td><font style="font-size: 10pt">%</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.00</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-indent: 0.5in"><font style="font-size: 10pt">Expected stock price volatility</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">143.57</font></td> <td><font style="font-size: 10pt">%</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">125.00</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-indent: 0.5in"><font style="font-size: 10pt">Expected forfeiture rate</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.00</font></td> <td><font style="font-size: 10pt">%</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.00</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-indent: 0.5in"><font style="font-size: 10pt">Expected life</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">5.09 years</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">4.60 years</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><font style="font-size: 10pt">The following non-qualified stock options were outstanding and exercisable at September 30, 2020:</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><font style="font-size: 10pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid"><font style="font-size: 10pt"><b>Expiry date</b></font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Exercise Price</b></font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of Options <br /> Outstanding</b></font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of <br /> Options <br /> Exercisable</b></font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="text-align: center"><font style="font-size: 10pt">$</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 46%; padding-left: 0.05in"><font style="font-size: 10pt">December 31, 2020</font></td> <td style="width: 5%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">0.05</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 5%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">1,200,000</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 5%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">1,200,000</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 0.05in"><font style="font-size: 10pt">November 14, 2021</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.07</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">750,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">750,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 0.05in"><font style="font-size: 10pt">December 31, 2022</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.06</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">800,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">800,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 0.05in"><font style="font-size: 10pt">August 31, 2023</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.08</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">600,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">600,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 0.05in"><font style="font-size: 10pt">November 8, 2023</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.09</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">15,000,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">15,000,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 0.05in"><font style="font-size: 10pt">May 5, 2023</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.13</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">1,600,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">1,600,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 0.05in"><font style="font-size: 10pt">July 14, 2024</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.26</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">18,500,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">18,500,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 0.05in"><font style="font-size: 10pt">November 17, 2024</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.11</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">15,000,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">11,250,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 0.05in"><font style="font-size: 10pt">March 26, 2026</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.14</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">22,000,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">22,000,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 0.05in"><font style="font-size: 10pt">May 5, 2026</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.11</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">650,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">487,500</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1pt; padding-left: 0.05in"><font style="font-size: 10pt">June 11, 2026</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 0.05in"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 0.05in; text-align: right"><font style="font-size: 10pt">0.12</font></td> <td style="padding-left: 0.05in"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 0.05in"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 0.05in"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 0.05in; text-align: right"><font style="font-size: 10pt">7,000,000</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 0.05in"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">7,000,000</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">83,100,000</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">79,187,500</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">As at September 30, 2020, the aggregate intrinsic value of the Company&#8217;s stock options is $458,165 (December 31, 2019 &#8211; $1,005,350).</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><font style="font-size: 10pt"><b>Note 6.&#160; Warrants</b></font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><font style="font-size: 10pt"><b>&#160;</b></font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">Warrant transactions for the nine months ended September 30, 2020 are summarized as follows:</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="3" style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of <br /> Warrants</b></font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted <br /> Average Exercise <br /> Price</b></font></td></tr> <tr style="vertical-align: bottom"> <td colspan="3"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="text-align: justify"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="text-align: justify"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 1%; padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 52%; padding-bottom: 1pt"><font style="font-size: 10pt">Balance,December 31, 2018 and September 30, 2019</font></td> <td style="width: 1%; padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%; padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; width: 1%; padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; width: 20%; padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">6,000,000</font></td> <td style="width: 1%; padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%; padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; width: 1%"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1pt solid; width: 20%; text-align: right"><font style="font-size: 10pt">0.26</font></td> <td style="width: 1%; padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Balance, December 31, 2019 and&#160;September 30, 2020</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">8,500,000</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.22</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt"><b>&#160;</b></font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">The following warrants were outstanding and exercisable as at September 30, 2020:</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"><font style="font-size: 10pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of Warrants</b></font></td> <td style="padding-bottom: 1pt; text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Exercise Price ($)</b></font></td> <td style="padding-bottom: 1pt; text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Expiry Date</b></font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 25%; text-align: right"><font style="font-size: 10pt">6,000,000</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 25%; text-align: right"><font style="font-size: 10pt">0.26</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 44%; text-align: right"><font style="font-size: 10pt">July 14, 2024</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">833,333</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.12</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">October 15, 2022</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">250,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.12</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">October 21, 2022</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">116,667</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.12</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">November 11, 2022</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">83,334</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.12</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">November 12, 2022</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">833,333</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.12</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">December 1, 2022</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">166,667</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.12</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">December 18, 2022</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="border-bottom: black 1pt solid"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">216,666</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">0.12</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">December 18, 2022</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="border-bottom: black 1pt solid"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">8,500,000</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">&#160;</font></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt"><b>Note 7.&#160; Stockholders&#8217; Equity</b></font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">The Company is authorized to issue 400,000,000 (December 31, 2019 &#8211; 400,000,000) shares of $0.0000053 par value common stock. Each holder of common stock has the right to one vote but does not have cumulative voting rights. Shares of common stock are not subject to any redemption or sinking fund provisions, nor do they have any preemptive, subscription or conversion rights. Holders of common stock are entitled to receive dividends whenever funds are legally available and when declared by the board of directors, subject to the prior rights of holders of all classes of stock outstanding having priority rights as to dividends. No dividends have been declared or paid as of September 30, 2020 (December 31, 2019 - $nil).</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">During the nine month period ended September 30, 2020, the Company:</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"><font style="font-size: 10pt">&#160;</font></td> <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"><font style="font-size: 10pt">a)</font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt">Issued 2,222,222 shares of common stock to investors at $0.09 for gross proceeds of $200,000.</font></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"><font style="font-size: 10pt">&#160;</font></td> <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"><font style="font-size: 10pt">b)</font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt">Issued 320,513 shares of common stock to investors at $0.078 for gross proceeds of $25,000.</font></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"><font style="font-size: 10pt">&#160;</font></td> <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"><font style="font-size: 10pt">c)</font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt">Issued 3,653,077 shares of common stock to investors at $0.065 for gross proceeds of $237,450. </font></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">During the nine month period ended September 30, 2019, the Company:</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"><font style="font-size: 10pt">&#160;</font></td> <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"><font style="font-size: 10pt">a)</font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt">Issued 750,000 shares of common stock to investors at $0.06 for gross proceeds of $45,000. </font></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"><font style="font-size: 10pt">&#160;</font></td> <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"><font style="font-size: 10pt">b)</font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt">Issued 10,000,000 shares of common stock to investors at $0.05 for gross proceeds of $500,000.</font></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 24px"><font style="font-size: 10pt">c)</font></td> <td><font style="font-size: 10pt">Issued 2,266,667 shares of common stock to investors at $0.12 for gross proceeds of $272,000.</font></td></tr> <tr style="vertical-align: top"> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">d)</font></td> <td><font style="font-size: 10pt">Issued 97,826 shares of common stock to the CFO pursuant to a cashless exercise of 250,000 stock options.</font></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt"><b>Note 8. Related Party Transactions and Balances</b></font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt"><b>&#160;</b></font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><font style="font-size: 10pt">During the nine month period ended September 30, 2020 and 2019, the Company entered into the following related party transactions:</font></p> <p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-left: 0"><font style="font-size: 10pt">a) Pursuant to a consulting agreement with an effective date of November 14, 2017, a total of $45,000 (2019 - $45,000) was paid or accrued to the Company's CFO. During the nine months ended September 30, 2020, the Company reimbursed a company controlled by the CFO a total of $9,450 (2019 - $9,450) in office rent.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0.8pt; margin-left: 0"><font style="font-size: 10pt">b) On March 25, 2020, the Company cancelled and concurrently approved for issuance on March 26, 2020 10,000,000 stock options and 2,000,000 stock options previously issued to the Company&#8217;s CEO and a Director of the Company in 2017, respectively. The 12,000,000 replacement options granted have a term of 6 years and are exercisable at a price of $0.14 per share, expiring on March 25, 2026.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0.8pt; margin-left: 0"><font style="font-size: 10pt">Also on March 25, 2020, the Company cancelled an additional 5,000,000 stock options previously issued to the Company&#8217;s CEO in 2019. There were no replacement options granted in connection with these cancelled options.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0.8pt; margin-left: 0"><font style="font-size: 10pt">In accordance with ASC 718, the 12,000,000 replacement options were accounted for as a modification of the terms of the cancelled award, with the incremental cost being measured as the excess of the fair value of the replacement options over the fair value of the cancelled options at the cancellation date.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0.8pt; margin-left: 0"><font style="font-size: 10pt">Total share-based compensation of $282,844 was recorded in connection with the option modification, based on the following assumptions used in the Black-Scholes Option Pricing Model: risk-free interest rate of 1.76%; dividend yield of 0.00%; stock price volatility of 144.40%; forfeiture rate of 0%; and an expected life of 6 years.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0.8pt; margin-left: 0"><font style="font-size: 10pt">b) On June 12, 2020, the Company cancelled 4,000,000 stock options previously issued in July 2019 to the Company&#8217;s CFO and a replaced them with 3,500,000 stock options. The 3,500,000 replacement options granted have a term of 6 years and are exercisable at a price of $0.12 per share, expiring on June 11, 2026.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0.8pt; margin-left: 0"><font style="font-size: 10pt">The 3,500,000 replacement options were accounted for as a modification of the terms of the cancelled award, with the incremental cost being measured as the excess of the fair value of the replacement options over the fair value of the cancelled options at the cancellation date.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0.8pt; margin-left: 0"><font style="font-size: 10pt">Total share-based compensation of $5,704 was recorded in connection with the option modification, based on the following assumptions used in the Black-Scholes Option Pricing Model: risk-free interest rate of 1.76%; dividend yield of 0.00%; stock price volatility of 144.75%; forfeiture rate of 0%; and an expected life of 6 years.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-left: 0"><font style="font-size: 10pt">c) The Company recognized $3,233,377 (2019 - $502,795) in share-based compensation during the period associated with stock options granted to key management personnel.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">As at September 30, 2020 and December 31, 2019, there were $nil balances owing to related parties.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt"><b>Note 9.&#160; Commitments and Contingency</b></font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">As at September 30, 2020, the Company has the following commitments:</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-left: 0"><font style="font-size: 10pt">a) Entered into a consulting agreement with an effective date of January 1, 2017 whereby the Company would pay the consultant $7,000 per month for providing research and development services. On March 25, 2020, the Company cancelled and concurrently approved for issuance on March 26, 2020, 10,000,000 stock options previously issued to the consultant in 2017. The 10,000,000 replacement options granted have a term of 6 years and are exercisable at a price of $0.14 per share, expiring on March 25, 2026.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-left: 0"><font style="font-size: 10pt">The 10,000,000 replacement options were accounted for as a modification of the terms of the cancelled award, with the incremental cost being measured as the excess of the fair value of the replacement options over the fair value of the cancelled options at the cancellation date.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-left: 0"><font style="font-size: 10pt">Total share-based compensation of $235,703 was recorded in connection with the option modification based on the following assumptions used in the Black-Scholes Option Pricing Model: risk-free interest rate of 0.81%; dividend yield of 0.00%; stock price volatility of 144.40%; forfeiture rate of 0%; and an expected life of 6 years.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-left: 0"><font style="font-size: 10pt">On June 12, 2020, the Company cancelled 4,000,000 stock options previously issued in July 2019 to the consultant and a replaced them with 3,500,000 stock options. The 3,500,000 replacement options granted have a term of 6 years and are exercisable at a price of $0.12 per share, expiring on June 11, 2026. There was no incremental cost recorded on the option modification based on the following assumptions used in the Black-Scholes Option Pricing Model: risk-free interest rate of 1.76%; dividend yield of 0.00%; stock price volatility of 144.75%; forfeiture rate of 0%; and an expected life of 6 years.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-left: 0"><font style="font-size: 10pt">b) Entered into a consulting agreement effective January 1, 2018, whereby the Company would pay the consultant $1,000 per month for a term of 1 year for providing public relations services, unless otherwise terminated by either party with at least 30 days&#8217; notice.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-left: 0"><font style="font-size: 10pt">c) Entered into a consulting agreement effective April 1, 2019, whereby the Company would pay the consultant $1,500 per month minimum plus travel expenses for a term of 1 year for providing research consulting services, unless otherwise terminated by either party with at least 30 days&#8217; notice. On May 6, 2020, the Company granted the consultant 500,000 stock options exercisable at a price of $0.11 per share, expiring on May 5, 2026 (Note 5).</font></p> <p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-left: 0"><font style="font-size: 10pt">d) Entered into a consulting agreement effective September 1, 2020, whereby the Company would pay the consultant CAD $3,000 per month for a term of 1 year for providing technical expertise and public relations services, unless otherwise terminated by either party with at least 30 days&#8217; notice.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt"><i>Contingency</i></font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">The Company was delinquent in filing certain income tax returns with the U.S. Internal Revenue Service and reports disclosing its interest in foreign bank accounts on form TDF 90-22.1, &#34;Report of Foreign Bank and Financial Accounts&#34; (&#34;FBARs&#34;). In September 2015, the Company filed the delinquent income tax returns and has sought waivers of any penalties under the IRS Offshore Voluntary Disclosure Program for late filing of the returns and FBARs.&#160; Under the program, the IRS has indicated that it will not impose a penalty for the failure to file delinquent income tax returns if there are no under reported tax liabilities.&#160; On November 30, 2017, the Company received a letter from the IRS concluding their review of the Company's tax returns under the program and accepting the returns as filed.&#160; No penalties have been assessed by the IRS to date, and management does not believe that the Company will incur any penalties relating to the tax years submitted under the program.</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">The following summarizes the Company&#8217;s prepaid expenses outstanding as at September 30, 2020 and December 31, 2019:</font></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>September 30, <br /> &#160;2020</b></font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, <br /> &#160; 2019</b></font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td colspan="3"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td colspan="3"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 66%; padding-bottom: 1pt; text-align: justify"><font style="font-size: 10pt">Rental deposit</font></td> <td style="width: 1%; padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; width: 1%; padding-bottom: 1pt"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1pt solid; width: 14%; padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">1,050</font></td> <td style="width: 1%; padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%; padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; width: 1%"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1pt solid; width: 14%; text-align: right"><font style="font-size: 10pt">1,050</font></td> <td style="width: 1%; padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">1,050</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,050</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">Intangible asset transactions are summarized as follows:</font></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0.1pt 0.1pt; text-align: justify"><font style="font-size: 10pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Patent Rights</b></font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Patent Application Rights</b></font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Total</b></font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt"><b>Cost</b></font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 55%; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Balance, December 31, 2018</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 12%; text-align: right"><font style="font-size: 10pt">30,000</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 12%; text-align: right"><font style="font-size: 10pt">168,271</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 12%; text-align: right"><font style="font-size: 10pt">198,271</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Additions</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">22,737</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">22,737</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Balance, December 31, 2019</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">30,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">191,008</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">221,008</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Additions</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">45,380</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">45,380</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Balance, September 30, 2020</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 5.4pt"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">30,000</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 5.4pt"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">236,388</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">266,388</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt"><b>Accumulated amortization</b></font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Balance, December 31, 2018</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">10,500</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">10,500</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Amortization</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">3,000</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">3,000</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Balance, December 31, 2019</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">13,500</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">13,500</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Amortization</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">2,250</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">2,250</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Balance,September 30, 2020</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 5.4pt"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">15,750</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 5.4pt"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">15,750</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt"><b>Net carrying amounts</b></font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">December 31, 2019</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">16,500</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">191,008</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">207,508</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">September 30, 2020</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 5.4pt"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">14,250</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 5.4pt"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">236,388</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">250,638</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">Stock option transactions are summarized as follows:</font></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt; text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of Stock Options</b></font></td> <td style="padding-bottom: 1pt; text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Exercise Price</b></font></td> <td style="padding-bottom: 1pt; text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Remaining Life</b></font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="padding-bottom: 1pt; text-align: center"><font style="font-size: 10pt"><b>$</b></font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="padding-bottom: 1pt; text-align: center"><font style="font-size: 10pt"><b>(Years)</b></font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 46%; padding-left: 5.4pt"><font style="font-size: 10pt">Outstanding, December 31, 2019</font></td> <td style="width: 5%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">91,450,000</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 5%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">0.14</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 5%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;Options cancelled</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">(36,000,000</font></td> <td><font style="font-size: 10pt">)</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.13</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;Options expired</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">(2,000,000</font></td> <td><font style="font-size: 10pt">)</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.04</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;Options granted</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">29,650,000</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">0.13</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-left: 15.3pt; text-indent: -15.3pt"><font style="font-size: 10pt">Outstanding, September 30, 2020</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 15.3pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 15.3pt; text-align: right"><font style="font-size: 10pt">83,100,000</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 15.3pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 15.3pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 15.3pt; text-align: right"><font style="font-size: 10pt">0.15</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 15.3pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 15.3pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">4.23</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt; text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of Stock Options</b></font></td> <td style="padding-bottom: 1pt; text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Exercise Price</b></font></td> <td style="padding-bottom: 1pt; text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Remaining Life</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt; text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="padding-bottom: 1pt; text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt; text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="padding-bottom: 1pt; text-align: center"><font style="font-size: 10pt"><b>$</b></font></td> <td style="padding-bottom: 1pt; text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="padding-bottom: 1pt; text-align: center"><font style="font-size: 10pt"><b>(Years)</b></font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 48%; padding-left: 5.4pt"><font style="font-size: 10pt">Outstanding, December 31, 2018</font></td> <td style="width: 3%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">58,600,000</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 5%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">0.07</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 5%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;Options cancelled</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">(16,000,000</font></td> <td><font style="font-size: 10pt">)</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.07</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;Options exercised</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">(250,000</font></td> <td><font style="font-size: 10pt">)&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.07</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;Options granted</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">34,100,000</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">0.25</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-left: 15.3pt; text-indent: -15.3pt"><font style="font-size: 10pt">Outstanding, September 30, 2019</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 15.3pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 15.3pt; text-align: right"><font style="font-size: 10pt">76,450,000</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 15.3pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 15.3pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 15.3pt; text-align: right"><font style="font-size: 10pt">0.15</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 15.3pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 15.3pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">3.48</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 5pt 0.2pt 0; text-align: justify"><font style="font-size: 10pt">The fair values of the stock options granted were estimated using the Black-Scholes Option Pricing Model, based on the following weighted average assumptions:</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 5pt 0.2pt 0; text-align: justify"><font style="font-size: 10pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>September 30, 2020</b></font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>September 30, 2019</b></font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 68%; text-indent: 0.5in"><font style="font-size: 10pt">Risk-free interest rate</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 13%; text-align: right"><font style="font-size: 10pt">2.55</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 13%; text-align: right"><font style="font-size: 10pt">2.41</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-indent: 0.5in"><font style="font-size: 10pt">Dividend yield</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.00</font></td> <td><font style="font-size: 10pt">%</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.00</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-indent: 0.5in"><font style="font-size: 10pt">Expected stock price volatility</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">143.57</font></td> <td><font style="font-size: 10pt">%</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">125.00</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-indent: 0.5in"><font style="font-size: 10pt">Expected forfeiture rate</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.00</font></td> <td><font style="font-size: 10pt">%</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.00</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-indent: 0.5in"><font style="font-size: 10pt">Expected life</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">5.09 years</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">4.60 years</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><font style="font-size: 10pt">The following non-qualified stock options were outstanding and exercisable at September 30, 2020:</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><font style="font-size: 10pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid"><font style="font-size: 10pt"><b>Expiry date</b></font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Exercise Price</b></font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of Options <br /> Outstanding</b></font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of <br /> Options <br /> Exercisable</b></font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="text-align: center"><font style="font-size: 10pt">$</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 46%; padding-left: 0.05in"><font style="font-size: 10pt">December 31, 2020</font></td> <td style="width: 5%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">0.05</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 5%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">1,200,000</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 5%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">1,200,000</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 0.05in"><font style="font-size: 10pt">November 14, 2021</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.07</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">750,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">750,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 0.05in"><font style="font-size: 10pt">December 31, 2022</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.06</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">800,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">800,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 0.05in"><font style="font-size: 10pt">August 31, 2023</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.08</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">600,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">600,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 0.05in"><font style="font-size: 10pt">November 8, 2023</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.09</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">15,000,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">15,000,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 0.05in"><font style="font-size: 10pt">May 5, 2023</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.13</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">1,600,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">1,600,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 0.05in"><font style="font-size: 10pt">July 14, 2024</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.26</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">18,500,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">18,500,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 0.05in"><font style="font-size: 10pt">November 17, 2024</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.11</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">15,000,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">11,250,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 0.05in"><font style="font-size: 10pt">March 26, 2026</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.14</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">22,000,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">22,000,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 0.05in"><font style="font-size: 10pt">May 5, 2026</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.11</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">650,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">487,500</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1pt; padding-left: 0.05in"><font style="font-size: 10pt">June 11, 2026</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 0.05in"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 0.05in; text-align: right"><font style="font-size: 10pt">0.12</font></td> <td style="padding-left: 0.05in"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 0.05in"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 0.05in"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; padding-left: 0.05in; text-align: right"><font style="font-size: 10pt">7,000,000</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-left: 0.05in"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">7,000,000</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">83,100,000</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">79,187,500</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">Warrant transactions for the nine months ended September 30, 2020 are summarized as follows:</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="3" style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of <br /> Warrants</b></font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted <br /> Average Exercise <br /> Price</b></font></td></tr> <tr style="vertical-align: bottom"> <td colspan="3"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="text-align: justify"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="text-align: justify"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 1%; padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 52%; padding-bottom: 1pt"><font style="font-size: 10pt">Balance,December 31, 2018 and September 30, 2019</font></td> <td style="width: 1%; padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%; padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; width: 1%; padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; width: 20%; padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">6,000,000</font></td> <td style="width: 1%; padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%; padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; width: 1%"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1pt solid; width: 20%; text-align: right"><font style="font-size: 10pt">0.26</font></td> <td style="width: 1%; padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Balance, December 31, 2019 and&#160;September 30, 2020</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">8,500,000</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.22</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">&#160;</font></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">The following warrants were outstanding and exercisable as at September 30, 2020:</font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"><font style="font-size: 10pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of Warrants</b></font></td> <td style="padding-bottom: 1pt; text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Exercise Price ($)</b></font></td> <td style="padding-bottom: 1pt; text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Expiry Date</b></font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 25%; text-align: right"><font style="font-size: 10pt">6,000,000</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 25%; text-align: right"><font style="font-size: 10pt">0.26</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 10pt">&#160;</font></td> <td style="width: 44%; text-align: right"><font style="font-size: 10pt">July 14, 2024</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">833,333</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.12</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">October 15, 2022</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">250,000</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.12</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">October 21, 2022</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">116,667</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.12</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">November 11, 2022</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">83,334</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.12</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">November 12, 2022</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">833,333</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.12</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">December 1, 2022</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">166,667</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.12</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 10pt">December 18, 2022</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="border-bottom: black 1pt solid"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">216,666</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">0.12</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">December 18, 2022</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="border-bottom: black 1pt solid"><font style="font-size: 10pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">8,500,000</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td> <td style="padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">&#160;</font></td></tr> </table> 560387 291451 245965 486967 1472 1506 1389 1459 1484 1458 36107058 42900764 31594822 33579381 41179346 33237164 -35548143 -42610819 -31350246 -33093873 -40923335 -32501945 257495 736677 275400259 281596071 259785766 272900259 277622481 272802433 6195812 13016667 3973590 462450 817000 262450 34 69 22 462416 816931 262428 97826 97826 1 1 -1 -1 6331290 1167629 1458990 342218 6331290 1167629 1458990 342218 -7062676 -1151699 -1687484 -591928 -7062676 -1743627 -1687484 -591928 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><u>Basis of Presentation</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying unaudited financial statements have been prepared by the Company in conformity with accounting principles generally accepted in the United States of America (&#8220;US GAAP&#8221;) applicable to interim financial information and with the rules and regulations of the United States Securities and Exchange Commission. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed, or omitted, pursuant to such rules and regulations. In the opinion of management, the unaudited interim financial statements include all adjustments necessary for the fair presentation of the results of the interim periods presented. All adjustments are of a normal recurring nature, except as otherwise noted below. These financial statements should be read in conjunction with the Company&#8217;s audited financial statements and notes thereto for the year ended December 31, 2019, included in the Company&#8217;s Annual Report on Form 10-K, filed February 19, 2020, with the Securities and Exchange Commission. The results of operations for the interim periods are not necessarily indicative of the results of operations for any other interim period or for a full fiscal year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><u>Use of Estimates</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period.&#160; Actual results could differ from those estimates.&#160; The more significant accounting estimates inherent in the preparation of the Company&#8217;s financial statements include estimates as to valuation of equity related instruments issued, deferred income taxes, and the useful life and impairment of intangible assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Cash</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash consists of funds held in checking accounts.&#160; Cash balances may exceed federally insured limits from time to time.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><u>Fair Value of Financial Instruments</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments, which includes cash and accounts payable and accrued liabilities, are carried at cost, which management believes approximates fair value due to the short-term nature of these instruments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company measures the fair value of financial assets and liabilities pursuant to ASC 820 &#8220;Fair Value Measurements and Disclosures&#8221; which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. ASC 820 establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The policy describes three levels of inputs that may be used to measure fair value:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 1 &#8211; quoted prices in active markets for identical assets or liabilities</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 2 &#8211; quoted prices for similar assets and liabilities in active markets or inputs that are observable</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 3 &#8211; inputs that are unobservable (for example cash flow modeling inputs based on assumptions)</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 1 inputs are used to measure cash. At September 30, 2020, there were no other assets or liabilities subject to additional disclosure.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Income Taxes</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for income taxes following the assets and liability method in accordance with the ASC 740 &#8220;Income Taxes.&#8221;&#160; Under such method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases.&#160; The Company applies the accounting guidance issued to address the accounting for uncertain tax positions.&#160; This guidance clarifies the accounting for income taxes, by prescribing a minimum recognition threshold a tax position is required to meet before being recognized in the financial statements as well as provides guidance on derecognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition.&#160; Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years that the asset is expected to be recovered or the liability settled.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Intangible assets &#8211; patent and patent application costs</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company owns intangible assets consisting of certain patents and patent applications. Intangible assets acquired separately are measured on initial recognition at cost. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and any accumulated impairment losses. Subsequent expenditures are capitalized only when they increase the future economic benefits embodied in the specific asset to which they relate. All other expenditures are recognized in profit or loss as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As at September 30, 2020, the Company does not hold any intangible assets with indefinite lives.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Intangible assets with finite lives are amortized over the useful economic life and assessed for impairment whenever there is an indication that the intangible asset may be impaired. The amortization method and amortization period of an intangible asset with a finite life is reviewed at least annually.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset is accounted for by changing the amortization period or method, as appropriate, and are treated as changes in accounting estimates. Amortization is recognized in profit or loss on a straight-line basis over the estimated useful lives of the Company&#8217;s patents. No amortization is recognized on patent application costs, as amortization of these costs will only commence once the patents have been granted.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Research and Development Costs</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Research and development costs are expensed as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><u>Loss per Share and Potentially Dilutive Securities</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Basic loss per share is computed by dividing the net loss available to common stockholders by the weighted average number of common shares outstanding in the period.&#160; Diluted loss per share takes into consideration common shares outstanding (computed under basic earnings per share) and potentially dilutive securities.&#160; The effect of 83,100,000 stock options (September 30, 2019 &#8211; 76,450,000), and 8,500,000 warrants (September 30, 2019 &#8211; 6,000,000) were not included in the computation of diluted earnings per share for all periods presented because it was anti-dilutive due to the Company&#8217;s losses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Share-Based Compensation</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has granted warrants and options to purchase shares of the Company&#8217;s common stock to various parties for consulting services.&#160; The fair values of the warrants and options issued have been estimated using the Black-Scholes Option Pricing Model.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for stock compensation with persons classified as employees for accounting purposes in accordance with ASC 718 &#8220;Compensation &#8211; Stock Compensation&#8221;, which recognizes awards at fair value on the date of grant and recognition of compensation over the service period for awards expected to vest. Cliff Vesting is used and awards vest on the last day of the vesting period. The fair value of stock options is determined using the Black-Scholes Option Pricing Model. The fair value of common shares issued for services is determined based on the Company&#8217;s stock price on the date of issuance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Share-based compensation for non-employees in exchange for goods and services used or consumed in an entity&#8217;s own operations are also recorded at fair value on the measurement date and accounted for in accordance with ASC 718. The measurement of share-based compensation is subject to periodic adjustment as the underlying instruments vest. The fair value of stock options is estimated using the Black-Scholes Option Pricing Model and the compensation charges are amortized over the vesting period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><u>Common stock</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Common stock issued for non-monetary consideration are recorded at their fair value on the measurement date and classified as equity. The measurement date is defined as the earliest of the date at which the commitment for performance by the counterparty to earn the common shares is reached or the date at which the counterparty&#8217;s performance is complete.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Transaction costs directly attributable to the issuance of common stock, units and stock options are recognized as a deduction from equity, net of any tax effects.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><u>Related Party Transactions</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A related party is generally defined as (i) any person that holds 10% or more of the Company&#8217;s securities and their immediate families, (ii) the Company&#8217;s management, (iii) someone that directly or indirectly controls, is controlled by or is under common control with the Company, or (iv) anyone who can significantly influence the financial and operating decisions of the Company.&#160; A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Recent Accounting Pronouncements</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.1pt">Certain new accounting pronouncements that have been issued are not expected to have a material effect on the Company&#8217;s financial statements.</p> EX-101.SCH 6 pktx-20200930.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - BALANCE SHEETS (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - STATEMENTS OF OPERATIONS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - STATEMENT OF STOCKHOLDERS’ EQUITY (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - STATEMENTS OF CASH FLOWS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - 1. Basis of Presentation - Going Concern Uncertainties link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - 2. Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - 3. Prepaid Expenses link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - 4. Intangible Assets link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - 5. Stock Options link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - 6. Warrants link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - 7. Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - 8. Related Party Transactions and Balances link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - 9. Commitments and Contingency link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - 2. Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - 3. Prepaid Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - 4. Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - 5. Stock Options (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - 6. Warrants (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - 2. Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - 3. Prepaid Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - 4. Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - 4. Intangible Assets (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - 5. Stock Options (Details) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - 5. Stock Options (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - 5. Stock Options (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - 5. Stock Options (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - 6. Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - 6. Warrants (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - 7. Stockholders' Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - 8. Related Party Transactions and Balances (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - 9. Commitments and Contingency (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 pktx-20200930_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 pktx-20200930_def.xml XBRL DEFINITION FILE EX-101.LAB 9 pktx-20200930_lab.xml XBRL LABEL FILE Finite-Lived Intangible Assets by Major Class [Axis] Patent Rights [Member] Patent Application Rights [Member] Related Party [Axis] Chief Financial Officer [Member] Antidilutive Securities [Axis] Warrant Award Type [Axis] Stock options Warrant One Investors Clarence Smith (CEO) Warrant Two Warrant Three Warrant Four Warrant Five Warrant Six Warrant Seven Warrant Eight Exercise Price Range [Axis] December 31, 2020 November 14, 2021 December 31, 2022 August 31, 2023 November 8, 2023 May 5, 2023 July 14, 2024 November 17, 2024 March 26, 2026 May 5, 2026 June 11, 2026 research and development and Business development Investors One Investors Two Investors One Equity Components [Axis] Common Stock Additional Paid-In Capital Accumulated Deficit Document and Entity Information [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Document Period End Date Current Fiscal Year End Date Entity File Number Entity Filer Category Entity Voluntary Filers Entity Well Known Seasoned Issuer Entity Current Reporting Status Entity Small Business Is Entity Emerging Growth Company? Entity Shell Company Entity Interactive Data Current Entity Incorporation State Country Code Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current Assets Cash Prepaid expenses (Note 3) Total current assets Intangible assets (Note 4) Total assets LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities Accounts payable and accrued liabilities Total current liabilities Stockholders' Equity Common stock, $0.0000053 par value; 400,000,000 common shares authorized; 281,596,071 and 275,400,259 shares issued and outstanding as at September 30, 2020 and December 31, 2019 respectively Additional paid-in capital Accumulated deficit Total stockholders' equity Total liabilities and stockholders' equity Common Stock, Par Value Per Share Common Stock, Shares Authorized Common Stock, Shares, Issued Common Stock, Shares, Outstanding Income Statement [Abstract] EXPENSES Amortization - intangible assets General and administrative Professional fees Research and development Share-based compensation Total Expenses OTHER ITEM Foreign exchange gain or (loss) Net loss for the period Net loss per common share (basic and diluted) Weighted average number of common shares outstanding (basic and diluted) Statement [Table] Statement [Line Items] Beginning Balance, Shares Beginning Balance, Amount Issuance of common stock pursuant to private placement offering, Shares Issuance of common stock pursuant to private placement offering, Amount Issuance of common stock pursuant to cashless option exercise, Share Issuance of common stock pursuant to cashless option exercise, Amount Share-based compensation Net Loss for the period Ending Balance, Shares Ending Balance, Amount Statement of Cash Flows [Abstract] CASH FLOWS USED IN OPERATING ACTIVITIES Net loss for the period Adjustments to reconcile net loss to cash used in operating activities: Fair value of share-based compensation Changes in operating assets and liabilities: Prepaid expenses Accounts payable and accrued liabilities Net cash used in operating activities CASH FLOWS USED IN INVESTING ACTIVITIES Purchase of Intangible assets Net cash used in investing activities CASH FLOWS FROM FINANCING ACTIVITIES Issuance of common stock for cash Net cash from financing activities Net change in cash Cash, beginning of period Cash, end of period Cash paid for interest Cash paid for income taxes Organization, Consolidation and Presentation of Financial Statements [Abstract] Basis of Presentation - Going Concern Uncertainties Accounting Policies [Abstract] Summary of Significant Accounting Policies Prepaid Expense, Current [Abstract] Prepaid Expenses Goodwill and Intangible Assets Disclosure [Abstract] Intangible Assets Stock Options Stock Options Warrants Warrants Stockholders' Equity Note [Abstract] Stockholders' Equity Related Party Transactions [Abstract] Related Party Transactions and Balances Commitments and Contingencies Disclosure [Abstract] Commitments and Contingency Basis of Presentation Use of Estimates Cash Fair Value of Financial Instruments Income Taxes Intangible assets - patent and patent application costs Research and Development Costs Loss per Share and Potentially Dilutive Securities Share-Based Compensation Common stock Related Party Transactions Recent Accounting Pronouncements Prepaid expenses and deposits outstanding Intangible asset transactions Schedule of Share-based Compensation, Stock Options, Activity Schedule of valuation assumptions for options Schedule of options by exercise price Schedule of Warrant Activity Schedule of Stockholders' Equity Note, Warrants or Rights Antidilutive Securities Excluded from Computation of Earnings Per Share Rental deposit Total Statistical Measurement [Axis] Cost Beginning balance Additions Ending balance Accumulated amortization Beginning balance Amortization Ending balance Net carrying amounts Direct cost Outstanding, beginning Options cancelled Options expired Options exercised Options granted Outstanding, ending Weighted average exercise price beginning balance Weighted Average Exercise Price, cacelled Weighted Average Exercise Price, expired Weighted Average Exercise Price, Options exercised Weighted Average Exercise Price, granted Weighed average exercise price ending balance Weighted Average Remaining Life (Years) Risk-free interest rate Dividend yield Expected stock price volatility Expected forfeiture rate Expected life Weighed average exercise price ending balance Outstanding, ending Number of options exercisable Common stock granted Aggregate intrinsic value Weighted average fair value of stock options granted per share Option description Warrant outstanding, ending Warrant weighted average exercise price Number of Warrants Warrant Exercise Price Expiry Date Dividends declared Common stock issued Share price Gross proceeds from issue of common stock Stock options exercise Share based Compensation Payment to CFO Office rent Due to related parties Stock price volatility Forfeiture rate Expected life (years) Share-based compensation Custom Element. Warrant Exercise Price Custom Element. Custom Element. Custom Element. Custom Element. Date 9 [Member] Document and Entity Information [Abstract] Custom Element. Custom Element. Custom Element. Custom Element. Schedule of Warrant Activity [Table Text Block] Stock Options [Text Block] Custom Element. Warrants [Text Block] InvestorsOneMember Assets, Current Assets Liabilities, Current Stockholders' Equity Attributable to Parent Liabilities and Equity Operating Expenses Shares, Issued Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture Increase (Decrease) in Prepaid Expense Increase (Decrease) in Accounts Payable and Accrued Liabilities Net Cash Provided by (Used in) Operating Activities Payments to Acquire Intangible Assets Net Cash Provided by (Used in) Investing Activities Net Cash Provided by (Used in) Financing Activities Cash and Cash Equivalents, Period Increase (Decrease) Stock Options [Text Block] Warrants [Text Block] Stockholders' Equity Note Disclosure [Text Block] Cash and Cash Equivalents, Policy [Policy Text Block] Finite-Lived Intangible Assets, Gross Finite-Lived Intangible Assets, Accumulated Amortization Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Share-based Payment Arrangement, Expense, after Tax EX-101.PRE 10 pktx-20200930_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.20.2
Document and Entity Information - shares
 9 Months Ended
Sep. 30, 2020
Oct. 16, 2020
Document and Entity Information [Abstract]    
Entity Registrant Name ProtoKinetix, Inc.  
Entity Central Index Key 0001128189  
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Sep. 30, 2020  
Current Fiscal Year End Date --12-31  
Entity File Number 000-32917  
Entity Filer Category Non-accelerated Filer  
Entity Current Reporting Status Yes  
Entity Small Business true  
Is Entity Emerging Growth Company? false  
Entity Shell Company false  
Entity Interactive Data Current Yes  
Entity Incorporation State Country Code NV  
Entity Common Stock, Shares Outstanding   281,596,071
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2020  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.20.2
BALANCE SHEETS (Unaudited) - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Current Assets    
Cash $ 44,763 $ 377,349
Prepaid expenses (Note 3) 1,050 1,050
Total current assets 45,813 378,399
Intangible assets (Note 4) 250,638 207,508
Total assets 296,451 585,907
Current Liabilities    
Accounts payable and accrued liabilities 5,000 25,520
Total current liabilities 5,000 25,520
Stockholders' Equity    
Common stock, $0.0000053 par value; 400,000,000 common shares authorized; 281,596,071 and 275,400,259 shares issued and outstanding as at September 30, 2020 and December 31, 2019 respectively 1,506 1,472
Additional paid-in capital 42,900,764 36,107,058
Accumulated deficit (42,610,819) (35,548,143)
Total stockholders' equity 291,451 560,387
Total liabilities and stockholders' equity $ 296,451 $ 585,907
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.20.2
BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares
Sep. 30, 2020
Dec. 31, 2019
Statement of Financial Position [Abstract]    
Common Stock, Par Value Per Share $ 0.0000053 $ 0.0000053
Common Stock, Shares Authorized 400,000,000 400,000,000
Common Stock, Shares, Issued 281,596,071 275,400,259
Common Stock, Shares, Outstanding 281,596,071 275,400,259
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.20.2
STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
EXPENSES        
Amortization - intangible assets $ 750 $ 750 $ 2,250 $ 2,250
General and administrative 46,460 76,905 174,480 202,238
Professional fees 39,063 31,032 116,112 92,315
Research and development 142,221 140,933 438,544 279,089
Share-based compensation 1,458,990 342,218 6,331,290 1,167,629
Total Expenses (1,687,484) (591,838) (7,062,676) (1,743,521)
OTHER ITEM        
Foreign exchange gain or (loss)   (90) 0 (106)
Net loss for the period $ (1,687,484) $ (591,928) $ (7,062,676) $ (1,743,627)
Net loss per common share (basic and diluted) $ (0.01) $ (0.00) $ (0.03) $ (0.01)
Weighted average number of common shares outstanding (basic and diluted) 279,648,342 272,816,256 277,211,051 267,232,714
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.20.2
STATEMENT OF STOCKHOLDERS’ EQUITY (Unaudited) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning Balance, Shares at Dec. 31, 2018 259,785,766      
Beginning Balance, Amount at Dec. 31, 2018 $ 1,389 $ 31,594,822 $ (31,350,246) $ 245,965
Issuance of common stock pursuant to private placement offering, Shares 13,016,667      
Issuance of common stock pursuant to private placement offering, Amount $ 69 816,931 817,000
Issuance of common stock pursuant to cashless option exercise, Share 97,826      
Issuance of common stock pursuant to cashless option exercise, Amount $ 1 (1)
Share-based compensation 1,167,629 1,167,629
Net Loss for the period (1,743,627) (1,151,699)
Ending Balance, Shares at Sep. 30, 2019 272,900,259      
Ending Balance, Amount at Sep. 30, 2019 $ 1,459 33,579,381 (33,093,873) 486,967
Beginning Balance, Shares at Jun. 30, 2019 272,802,433      
Beginning Balance, Amount at Jun. 30, 2019 $ 1,458 33,237,164 (32,501,945) 736,677
Issuance of common stock pursuant to cashless option exercise, Share 97,826      
Issuance of common stock pursuant to cashless option exercise, Amount $ 1 (1)
Share-based compensation 342,218 342,218
Net Loss for the period (591,928) (591,928)
Ending Balance, Shares at Sep. 30, 2019 272,900,259      
Ending Balance, Amount at Sep. 30, 2019 $ 1,459 33,579,381 (33,093,873) 486,967
Beginning Balance, Shares at Dec. 31, 2019 275,400,259      
Beginning Balance, Amount at Dec. 31, 2019 $ 1,472 36,107,058 (35,548,143) 560,387
Issuance of common stock pursuant to private placement offering, Shares 6,195,812      
Issuance of common stock pursuant to private placement offering, Amount $ 34 462,416 462,450
Share-based compensation 6,331,290 6,331,290
Net Loss for the period (7,062,676) (7,062,676)
Ending Balance, Shares at Sep. 30, 2020 281,596,071      
Ending Balance, Amount at Sep. 30, 2020 $ 1,506 42,900,764 (42,610,819) 291,451
Beginning Balance, Shares at Jun. 30, 2020 277,622,481      
Beginning Balance, Amount at Jun. 30, 2020 $ 1,484 41,179,346 (40,923,335) 257,495
Issuance of common stock pursuant to private placement offering, Shares 3,973,590      
Issuance of common stock pursuant to private placement offering, Amount $ 22 262,428 262,450
Share-based compensation 1,458,990 1,458,990
Net Loss for the period (1,687,484) (1,687,484)
Ending Balance, Shares at Sep. 30, 2020 281,596,071      
Ending Balance, Amount at Sep. 30, 2020 $ 1,506 $ 42,900,764 $ (42,610,819) $ 291,451
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.20.2
STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
CASH FLOWS USED IN OPERATING ACTIVITIES    
Net loss for the period $ (7,062,676) $ (1,743,627)
Adjustments to reconcile net loss to cash used in operating activities:    
Amortization - intangible assets 2,250 2,250
Fair value of share-based compensation 6,331,290 1,167,629
Changes in operating assets and liabilities:    
Prepaid expenses 0 (9,540)
Accounts payable and accrued liabilities (20,520) (73,464)
Net cash used in operating activities (749,656) (656,752)
CASH FLOWS USED IN INVESTING ACTIVITIES    
Purchase of Intangible assets (45,380) (6,418)
Net cash used in investing activities (45,380) (6,418)
CASH FLOWS FROM FINANCING ACTIVITIES    
Issuance of common stock for cash 462,450 817,000
Net cash from financing activities 462,450 817,000
Net change in cash (332,586) 153,830
Cash, beginning of period 377,349 136,029
Cash, end of period 44,763 289,859
Cash paid for interest 0 0
Cash paid for income taxes $ 0 $ 0
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.20.2
1. Basis of Presentation - Going Concern Uncertainties
 9 Months Ended
Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation - Going Concern Uncertainties

Note 1.  Basis of Presentation – Going Concern Uncertainties

 

ProtoKinetix, Incorporated (the “Company”), a development stage company, was incorporated under the laws of the State of Nevada on December 23, 1999.  The Company is a medical research company whose mission is the advancement of human health care.

 

The Company is currently researching the benefits and feasibility of synthesized Antifreeze Glycoproteins (“AFGP”) or anti-aging glycoproteins, trademarked AAGP.  During the year ended December 31, 2015, the Company acquired certain patents and rights for cash consideration of $30,000 (25,000 Euros), as well as additional patent applications for cash consideration of $10,000 and 6,000,000 share purchase warrants with a fair value of $25,000 (Note 4).

 

The Company’s financial statements are prepared consistent with accounting principles generally accepted in the United States applicable to a going concern.

 

The Company has not developed a commercially viable product, has not generated any significant revenue to date, and has incurred losses since inception, resulting in a net accumulated deficit at September 30, 2020.  These factors raise substantial doubt about the Company’s ability to continue as a going concern.

 

The Company needs additional working capital to continue its medical research or to be successful in any future business activities and continue to pay its liabilities.  Therefore, continuation of the Company as a going concern is dependent upon obtaining the additional working capital necessary to accomplish its objective.  Management is presently engaged in seeking additional working capital through equity financing or related party loans.

 

In March 2020, the World Health Organization declared coronavirus COVID-19 a global pandemic. This contagious disease outbreak, which has continued to spread, and any related adverse public health developments, has adversely affected workforces, economies, and financial markets globally, potentially leading to an economic downturn. It is not possible for the Company to predict the duration or magnitude of the adverse results of the outbreak and its effects on the Company’s business or ability to raise funds.

 

The accompanying financial statements do not include any adjustments to the recorded assets or liabilities that might be necessary should the Company fail in any of the above objectives and is unable to operate for the coming year.
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.20.2
2. Summary of Significant Accounting Policies
 9 Months Ended
Sep. 30, 2020
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

Note 2. Summary of Significant Accounting Policies

 

Basis of Presentation

 

The accompanying unaudited financial statements have been prepared by the Company in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) applicable to interim financial information and with the rules and regulations of the United States Securities and Exchange Commission. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed, or omitted, pursuant to such rules and regulations. In the opinion of management, the unaudited interim financial statements include all adjustments necessary for the fair presentation of the results of the interim periods presented. All adjustments are of a normal recurring nature, except as otherwise noted below. These financial statements should be read in conjunction with the Company’s audited financial statements and notes thereto for the year ended December 31, 2019, included in the Company’s Annual Report on Form 10-K, filed February 19, 2020, with the Securities and Exchange Commission. The results of operations for the interim periods are not necessarily indicative of the results of operations for any other interim period or for a full fiscal year.

 

Use of Estimates

 

Preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period.  Actual results could differ from those estimates.  The more significant accounting estimates inherent in the preparation of the Company’s financial statements include estimates as to valuation of equity related instruments issued, deferred income taxes, and the useful life and impairment of intangible assets.

 

Cash

 

Cash consists of funds held in checking accounts.  Cash balances may exceed federally insured limits from time to time.

 

Fair Value of Financial Instruments

 

Financial instruments, which includes cash and accounts payable and accrued liabilities, are carried at cost, which management believes approximates fair value due to the short-term nature of these instruments.

 

The Company measures the fair value of financial assets and liabilities pursuant to ASC 820 “Fair Value Measurements and Disclosures” which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. ASC 820 establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The policy describes three levels of inputs that may be used to measure fair value:

 

Level 1 – quoted prices in active markets for identical assets or liabilities

Level 2 – quoted prices for similar assets and liabilities in active markets or inputs that are observable

Level 3 – inputs that are unobservable (for example cash flow modeling inputs based on assumptions)

 

Level 1 inputs are used to measure cash. At September 30, 2020, there were no other assets or liabilities subject to additional disclosure.

 

Income Taxes

 

The Company accounts for income taxes following the assets and liability method in accordance with the ASC 740 “Income Taxes.”  Under such method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases.  The Company applies the accounting guidance issued to address the accounting for uncertain tax positions.  This guidance clarifies the accounting for income taxes, by prescribing a minimum recognition threshold a tax position is required to meet before being recognized in the financial statements as well as provides guidance on derecognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years that the asset is expected to be recovered or the liability settled.

 

Intangible assets – patent and patent application costs

 

The Company owns intangible assets consisting of certain patents and patent applications. Intangible assets acquired separately are measured on initial recognition at cost. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and any accumulated impairment losses. Subsequent expenditures are capitalized only when they increase the future economic benefits embodied in the specific asset to which they relate. All other expenditures are recognized in profit or loss as incurred.

 

As at September 30, 2020, the Company does not hold any intangible assets with indefinite lives.

 

Intangible assets with finite lives are amortized over the useful economic life and assessed for impairment whenever there is an indication that the intangible asset may be impaired. The amortization method and amortization period of an intangible asset with a finite life is reviewed at least annually.

 

Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset is accounted for by changing the amortization period or method, as appropriate, and are treated as changes in accounting estimates. Amortization is recognized in profit or loss on a straight-line basis over the estimated useful lives of the Company’s patents. No amortization is recognized on patent application costs, as amortization of these costs will only commence once the patents have been granted.

 

Research and Development Costs

 

Research and development costs are expensed as incurred.

 

Loss per Share and Potentially Dilutive Securities

 

Basic loss per share is computed by dividing the net loss available to common stockholders by the weighted average number of common shares outstanding in the period.  Diluted loss per share takes into consideration common shares outstanding (computed under basic earnings per share) and potentially dilutive securities.  The effect of 83,100,000 stock options (September 30, 2019 – 76,450,000), and 8,500,000 warrants (September 30, 2019 – 6,000,000) were not included in the computation of diluted earnings per share for all periods presented because it was anti-dilutive due to the Company’s losses.

 

Share-Based Compensation

 

The Company has granted warrants and options to purchase shares of the Company’s common stock to various parties for consulting services.  The fair values of the warrants and options issued have been estimated using the Black-Scholes Option Pricing Model.

 

The Company accounts for stock compensation with persons classified as employees for accounting purposes in accordance with ASC 718 “Compensation – Stock Compensation”, which recognizes awards at fair value on the date of grant and recognition of compensation over the service period for awards expected to vest. Cliff Vesting is used and awards vest on the last day of the vesting period. The fair value of stock options is determined using the Black-Scholes Option Pricing Model. The fair value of common shares issued for services is determined based on the Company’s stock price on the date of issuance.

 

Share-based compensation for non-employees in exchange for goods and services used or consumed in an entity’s own operations are also recorded at fair value on the measurement date and accounted for in accordance with ASC 718. The measurement of share-based compensation is subject to periodic adjustment as the underlying instruments vest. The fair value of stock options is estimated using the Black-Scholes Option Pricing Model and the compensation charges are amortized over the vesting period.

 

Common stock

 

Common stock issued for non-monetary consideration are recorded at their fair value on the measurement date and classified as equity. The measurement date is defined as the earliest of the date at which the commitment for performance by the counterparty to earn the common shares is reached or the date at which the counterparty’s performance is complete.

 

Transaction costs directly attributable to the issuance of common stock, units and stock options are recognized as a deduction from equity, net of any tax effects.

 

Related Party Transactions

 

A related party is generally defined as (i) any person that holds 10% or more of the Company’s securities and their immediate families, (ii) the Company’s management, (iii) someone that directly or indirectly controls, is controlled by or is under common control with the Company, or (iv) anyone who can significantly influence the financial and operating decisions of the Company.  A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties.

 

Recent Accounting Pronouncements

 

Certain new accounting pronouncements that have been issued are not expected to have a material effect on the Company’s financial statements.
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.20.2
3. Prepaid Expenses
 9 Months Ended
Sep. 30, 2020
Prepaid Expense, Current [Abstract]  
Prepaid Expenses

Note 3.   Prepaid Expenses

 

The following summarizes the Company’s prepaid expenses outstanding as at September 30, 2020 and December 31, 2019:

 

    September 30,
 2020		   December 31,
  2019
         
Rental deposit   $ 1,050     $ 1,050  
                 
    $ 1,050     $ 1,050  
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.20.2
4. Intangible Assets
 9 Months Ended
Sep. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets

Note 4.   Intangible Assets

 

Intangible asset transactions are summarized as follows:

 

    Patent Rights   Patent Application Rights   Total
Cost                        
Balance, December 31, 2018   $ 30,000     $ 168,271     $ 198,271  
Additions     —         22,737       22,737  
Balance, December 31, 2019   $ 30,000     $ 191,008     $ 221,008  
Additions     —         45,380       45,380  
Balance, September 30, 2020   $ 30,000     $ 236,388     $ 266,388  
                         
Accumulated amortization                        
Balance, December 31, 2018   $ 10,500     $ —       $ 10,500  
Amortization     3,000       —         3,000  
Balance, December 31, 2019   $ 13,500     $ —       $ 13,500  
Amortization     2,250       —         2,250  
Balance,September 30, 2020   $ 15,750     $ —       $ 15,750  
                         
Net carrying amounts                        
December 31, 2019   $ 16,500     $ 191,008     $ 207,508  
September 30, 2020   $ 14,250     $ 236,388     $ 250,638  

 

During the year ended December 31, 2015, the Company entered into an Assignment of Patents and Patent Application (effective January 1, 2015) (the “Patent Assignment”) with the Institut National des Sciences Appliquees de Rouen (“INSA”) for the assignment of certain patents and all rights associated therewith (the “Patents”). The Company and INSA had previously entered into a licensing agreement for the Patents in August 2004. The Patent Assignment transfers all of the Patents and rights associated therewith to the Company, upon payment to INSA in the sum of $30,000. During the nine month period ended September 30, 2020, the Company recorded $2,250 (2019 - $2,250) in amortization expense associated with the Patents.

 

During the year ended December 31, 2015, the Company entered into a Technology Transfer Agreement with Grant Young for the assignment of his 50% ownership of certain patents and all rights associated therewith (the “Patent Application Rights”).  In exchange for the Patent Application Rights, the Company agreed to pay $10,000 (paid) and to issue 6,000,000 warrants (issued) to purchase shares of the Company’s common stock at an exercise price of $0.10 per share for a period of five years. The Patent Application Rights had a total fair value of $35,000, which was allocated as $10,000 to the cash consideration paid, with the remaining $25,000 being allocated to the warrant component of the overall consideration. The Company has incurred $201,388 in direct costs relating to the Patent Application Rights, $45,380 of which were incurred during the nine month period ended September 30, 2020.

 

The remaining 50% ownership of the Patent Application Rights was acquired from the Governors of the University of Alberta in exchange for a future gross revenue royalty.

 

During the year ended December 31, 2016, the Company entered into a Universal Assignment with Grant Young for the assignment of his ownership of certain new and useful improvements in an invention entitled “Use of Anti-Aging Glycoprotein for Enhancing Survival of Neurosensory Precursor Cells” (the “New Patent Application Rights”).  In exchange for the New Patent Application Rights, the Company agreed to pay $1 (paid).  The Company incurred $2,415 in direct costs relating to the New Patent Application Rights during the year ended December 31, 2016.

 

No amortization was recorded on the Patent Application Rights to September 30, 2020.
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.20.2
5. Stock Options
 9 Months Ended
Sep. 30, 2020
Stock Options  
Stock Options

Note 5.  Stock Options

Pursuant to an amendment on April 6, 2020, the aggregate number of shares that may be issued under the 2017 Stock Option and Stock Bonus Plan (the “2017 Plan”) is 85,700,000 shares, subject to adjustment as provided therein. The 2017 Plan is administered by the Company’s Board of Directors, or a committee appointed by the Board of Directors, and includes two types of options. Options intended to qualify as incentive stock options under Section 422 of the Internal Revenue Code of 1986, as amended, are referred to as incentive options. Options that are not intended to qualify as incentive options are referred to as non-qualified options. The exercise price of an option may be paid in cash, in shares of the Company's common stock or other property having a fair market value equal to the exercise price of the option, or in a combination of cash, shares, other securities and property.

As of September 30, 2020, there are 83,100,000 options granted and outstanding under the 2017 Plan.

Stock option transactions are summarized as follows:

    Number of Stock Options   Weighted Average Exercise Price   Weighted Average Remaining Life
        $   (Years)
Outstanding, December 31, 2019     91,450,000       0.14          
      Options cancelled     (36,000,000 )     0.13          
      Options expired     (2,000,000 )     0.04          
      Options granted     29,650,000       0.13          
Outstanding, September 30, 2020     83,100,000       0.15       4.23  
                         

 

    Number of Stock Options   Weighted Average Exercise Price   Weighted Average Remaining Life
        $   (Years)
Outstanding, December 31, 2018     58,600,000       0.07          
      Options cancelled     (16,000,000 )     0.07          
      Options exercised     (250,000 )      0.07          
      Options granted     34,100,000       0.25          
Outstanding, September 30, 2019     76,450,000       0.15       3.48  

 

On May 6, 2020, the Company granted 650,000 stock options to a research and development, and a business development consultant of the Company. The options are exercisable at $0.11 per share for a period of six years and expire on May 5, 2026. The options vest in equal instalments starting on the date of grant with the remaining options vesting on a quarterly basis beginning on June 30, 2020.

The Company granted 22,000,000 replacement options and 7,000,000 replacement options on March 26, 2020 and June 12, 2020, respectively, to certain key management (Note 8) and a consultant (Note 9) of the Company. Total share-based compensation for 29,650,000 stock options granted (2019 - 34,100,000) and vested during the nine month period ended September 30, 2020 was $6,331,290 (2019 - $1,167,629) at a weighted average fair value per option of $0.12 (2019 - $0.07). The fair values of the stock options granted were estimated using the Black-Scholes Option Pricing Model, based on the following weighted average assumptions:

 

    September 30, 2020   September 30, 2019
Risk-free interest rate     2.55 %     2.41 %
Dividend yield     0.00 %     0.00 %
Expected stock price volatility     143.57 %     125.00 %
Expected forfeiture rate     0.00 %     0.00 %
Expected life     5.09 years       4.60 years  
                 

 

The following non-qualified stock options were outstanding and exercisable at September 30, 2020:

 

Expiry date   Exercise Price   Number of Options
Outstanding		   Number of
Options
Exercisable
    $        
December 31, 2020     0.05       1,200,000       1,200,000  
November 14, 2021     0.07       750,000       750,000  
December 31, 2022     0.06       800,000       800,000  
August 31, 2023     0.08       600,000       600,000  
November 8, 2023     0.09       15,000,000       15,000,000  
May 5, 2023     0.13       1,600,000       1,600,000  
July 14, 2024     0.26       18,500,000       18,500,000  
November 17, 2024     0.11       15,000,000       11,250,000  
March 26, 2026     0.14       22,000,000       22,000,000  
May 5, 2026     0.11       650,000       487,500  
June 11, 2026     0.12       7,000,000       7,000,000  
              83,100,000       79,187,500  

 

As at September 30, 2020, the aggregate intrinsic value of the Company’s stock options is $458,165 (December 31, 2019 – $1,005,350).
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.20.2
6. Warrants
 9 Months Ended
Sep. 30, 2020
Warrants  
Warrants

Note 6.  Warrants

 

Warrant transactions for the nine months ended September 30, 2020 are summarized as follows:

 

    Number of
Warrants		   Weighted
Average Exercise
Price
         
  Balance,December 31, 2018 and September 30, 2019       6,000,000     $ 0.26  
  Balance, December 31, 2019 and September 30, 2020       8,500,000     $ 0.22  

 

 

The following warrants were outstanding and exercisable as at September 30, 2020:

 

Number of Warrants   Exercise Price ($)   Expiry Date
  6,000,000       0.26     July 14, 2024
  833,333       0.12     October 15, 2022
  250,000       0.12     October 21, 2022
  116,667       0.12     November 11, 2022
  83,334       0.12     November 12, 2022
  833,333       0.12     December 1, 2022
  166,667       0.12     December 18, 2022
  216,666       0.12     December 18, 2022
  8,500,000              
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.20.2
7. Stockholders' Equity
 9 Months Ended
Sep. 30, 2020
Stockholders' Equity Note [Abstract]  
Stockholders' Equity

Note 7.  Stockholders’ Equity

 

The Company is authorized to issue 400,000,000 (December 31, 2019 – 400,000,000) shares of $0.0000053 par value common stock. Each holder of common stock has the right to one vote but does not have cumulative voting rights. Shares of common stock are not subject to any redemption or sinking fund provisions, nor do they have any preemptive, subscription or conversion rights. Holders of common stock are entitled to receive dividends whenever funds are legally available and when declared by the board of directors, subject to the prior rights of holders of all classes of stock outstanding having priority rights as to dividends. No dividends have been declared or paid as of September 30, 2020 (December 31, 2019 - $nil).

 

During the nine month period ended September 30, 2020, the Company:

 

  a) Issued 2,222,222 shares of common stock to investors at $0.09 for gross proceeds of $200,000.

 

  b) Issued 320,513 shares of common stock to investors at $0.078 for gross proceeds of $25,000.

 

  c) Issued 3,653,077 shares of common stock to investors at $0.065 for gross proceeds of $237,450.

 

During the nine month period ended September 30, 2019, the Company:

 

  a) Issued 750,000 shares of common stock to investors at $0.06 for gross proceeds of $45,000.

 

  b) Issued 10,000,000 shares of common stock to investors at $0.05 for gross proceeds of $500,000.

 

  c) Issued 2,266,667 shares of common stock to investors at $0.12 for gross proceeds of $272,000.
  d) Issued 97,826 shares of common stock to the CFO pursuant to a cashless exercise of 250,000 stock options.
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.20.2
8. Related Party Transactions and Balances
 9 Months Ended
Sep. 30, 2020
Related Party Transactions [Abstract]  
Related Party Transactions and Balances

Note 8. Related Party Transactions and Balances

 

During the nine month period ended September 30, 2020 and 2019, the Company entered into the following related party transactions:

a) Pursuant to a consulting agreement with an effective date of November 14, 2017, a total of $45,000 (2019 - $45,000) was paid or accrued to the Company's CFO. During the nine months ended September 30, 2020, the Company reimbursed a company controlled by the CFO a total of $9,450 (2019 - $9,450) in office rent.

b) On March 25, 2020, the Company cancelled and concurrently approved for issuance on March 26, 2020 10,000,000 stock options and 2,000,000 stock options previously issued to the Company’s CEO and a Director of the Company in 2017, respectively. The 12,000,000 replacement options granted have a term of 6 years and are exercisable at a price of $0.14 per share, expiring on March 25, 2026.

Also on March 25, 2020, the Company cancelled an additional 5,000,000 stock options previously issued to the Company’s CEO in 2019. There were no replacement options granted in connection with these cancelled options.

In accordance with ASC 718, the 12,000,000 replacement options were accounted for as a modification of the terms of the cancelled award, with the incremental cost being measured as the excess of the fair value of the replacement options over the fair value of the cancelled options at the cancellation date.

Total share-based compensation of $282,844 was recorded in connection with the option modification, based on the following assumptions used in the Black-Scholes Option Pricing Model: risk-free interest rate of 1.76%; dividend yield of 0.00%; stock price volatility of 144.40%; forfeiture rate of 0%; and an expected life of 6 years.

b) On June 12, 2020, the Company cancelled 4,000,000 stock options previously issued in July 2019 to the Company’s CFO and a replaced them with 3,500,000 stock options. The 3,500,000 replacement options granted have a term of 6 years and are exercisable at a price of $0.12 per share, expiring on June 11, 2026.

The 3,500,000 replacement options were accounted for as a modification of the terms of the cancelled award, with the incremental cost being measured as the excess of the fair value of the replacement options over the fair value of the cancelled options at the cancellation date.

Total share-based compensation of $5,704 was recorded in connection with the option modification, based on the following assumptions used in the Black-Scholes Option Pricing Model: risk-free interest rate of 1.76%; dividend yield of 0.00%; stock price volatility of 144.75%; forfeiture rate of 0%; and an expected life of 6 years.

c) The Company recognized $3,233,377 (2019 - $502,795) in share-based compensation during the period associated with stock options granted to key management personnel.

As at September 30, 2020 and December 31, 2019, there were $nil balances owing to related parties.
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.20.2
9. Commitments and Contingency
 9 Months Ended
Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingency

Note 9.  Commitments and Contingency

 

As at September 30, 2020, the Company has the following commitments:

 

a) Entered into a consulting agreement with an effective date of January 1, 2017 whereby the Company would pay the consultant $7,000 per month for providing research and development services. On March 25, 2020, the Company cancelled and concurrently approved for issuance on March 26, 2020, 10,000,000 stock options previously issued to the consultant in 2017. The 10,000,000 replacement options granted have a term of 6 years and are exercisable at a price of $0.14 per share, expiring on March 25, 2026.

The 10,000,000 replacement options were accounted for as a modification of the terms of the cancelled award, with the incremental cost being measured as the excess of the fair value of the replacement options over the fair value of the cancelled options at the cancellation date.

Total share-based compensation of $235,703 was recorded in connection with the option modification based on the following assumptions used in the Black-Scholes Option Pricing Model: risk-free interest rate of 0.81%; dividend yield of 0.00%; stock price volatility of 144.40%; forfeiture rate of 0%; and an expected life of 6 years.

On June 12, 2020, the Company cancelled 4,000,000 stock options previously issued in July 2019 to the consultant and a replaced them with 3,500,000 stock options. The 3,500,000 replacement options granted have a term of 6 years and are exercisable at a price of $0.12 per share, expiring on June 11, 2026. There was no incremental cost recorded on the option modification based on the following assumptions used in the Black-Scholes Option Pricing Model: risk-free interest rate of 1.76%; dividend yield of 0.00%; stock price volatility of 144.75%; forfeiture rate of 0%; and an expected life of 6 years.

b) Entered into a consulting agreement effective January 1, 2018, whereby the Company would pay the consultant $1,000 per month for a term of 1 year for providing public relations services, unless otherwise terminated by either party with at least 30 days’ notice.

c) Entered into a consulting agreement effective April 1, 2019, whereby the Company would pay the consultant $1,500 per month minimum plus travel expenses for a term of 1 year for providing research consulting services, unless otherwise terminated by either party with at least 30 days’ notice. On May 6, 2020, the Company granted the consultant 500,000 stock options exercisable at a price of $0.11 per share, expiring on May 5, 2026 (Note 5).

d) Entered into a consulting agreement effective September 1, 2020, whereby the Company would pay the consultant CAD $3,000 per month for a term of 1 year for providing technical expertise and public relations services, unless otherwise terminated by either party with at least 30 days’ notice.

Contingency

 

The Company was delinquent in filing certain income tax returns with the U.S. Internal Revenue Service and reports disclosing its interest in foreign bank accounts on form TDF 90-22.1, "Report of Foreign Bank and Financial Accounts" ("FBARs"). In September 2015, the Company filed the delinquent income tax returns and has sought waivers of any penalties under the IRS Offshore Voluntary Disclosure Program for late filing of the returns and FBARs.  Under the program, the IRS has indicated that it will not impose a penalty for the failure to file delinquent income tax returns if there are no under reported tax liabilities.  On November 30, 2017, the Company received a letter from the IRS concluding their review of the Company's tax returns under the program and accepting the returns as filed.  No penalties have been assessed by the IRS to date, and management does not believe that the Company will incur any penalties relating to the tax years submitted under the program.
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.20.2
2. Summary of Significant Accounting Policies (Policies)
 9 Months Ended
Sep. 30, 2020
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

 

The accompanying unaudited financial statements have been prepared by the Company in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) applicable to interim financial information and with the rules and regulations of the United States Securities and Exchange Commission. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed, or omitted, pursuant to such rules and regulations. In the opinion of management, the unaudited interim financial statements include all adjustments necessary for the fair presentation of the results of the interim periods presented. All adjustments are of a normal recurring nature, except as otherwise noted below. These financial statements should be read in conjunction with the Company’s audited financial statements and notes thereto for the year ended December 31, 2019, included in the Company’s Annual Report on Form 10-K, filed February 19, 2020, with the Securities and Exchange Commission. The results of operations for the interim periods are not necessarily indicative of the results of operations for any other interim period or for a full fiscal year.
Use of Estimates

Use of Estimates

 

Preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period.  Actual results could differ from those estimates.  The more significant accounting estimates inherent in the preparation of the Company’s financial statements include estimates as to valuation of equity related instruments issued, deferred income taxes, and the useful life and impairment of intangible assets.
Cash

Cash

 

Cash consists of funds held in checking accounts.  Cash balances may exceed federally insured limits from time to time.
Fair Value of Financial Instruments

Fair Value of Financial Instruments

 

Financial instruments, which includes cash and accounts payable and accrued liabilities, are carried at cost, which management believes approximates fair value due to the short-term nature of these instruments.

 

The Company measures the fair value of financial assets and liabilities pursuant to ASC 820 “Fair Value Measurements and Disclosures” which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. ASC 820 establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The policy describes three levels of inputs that may be used to measure fair value:

 

Level 1 – quoted prices in active markets for identical assets or liabilities

Level 2 – quoted prices for similar assets and liabilities in active markets or inputs that are observable

Level 3 – inputs that are unobservable (for example cash flow modeling inputs based on assumptions)

 

Level 1 inputs are used to measure cash. At September 30, 2020, there were no other assets or liabilities subject to additional disclosure.
Income Taxes

Income Taxes

 

The Company accounts for income taxes following the assets and liability method in accordance with the ASC 740 “Income Taxes.”  Under such method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases.  The Company applies the accounting guidance issued to address the accounting for uncertain tax positions.  This guidance clarifies the accounting for income taxes, by prescribing a minimum recognition threshold a tax position is required to meet before being recognized in the financial statements as well as provides guidance on derecognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years that the asset is expected to be recovered or the liability settled.
Intangible assets - patent and patent application costs

Intangible assets – patent and patent application costs

 

The Company owns intangible assets consisting of certain patents and patent applications. Intangible assets acquired separately are measured on initial recognition at cost. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and any accumulated impairment losses. Subsequent expenditures are capitalized only when they increase the future economic benefits embodied in the specific asset to which they relate. All other expenditures are recognized in profit or loss as incurred.

 

As at September 30, 2020, the Company does not hold any intangible assets with indefinite lives.

 

Intangible assets with finite lives are amortized over the useful economic life and assessed for impairment whenever there is an indication that the intangible asset may be impaired. The amortization method and amortization period of an intangible asset with a finite life is reviewed at least annually.

 

Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset is accounted for by changing the amortization period or method, as appropriate, and are treated as changes in accounting estimates. Amortization is recognized in profit or loss on a straight-line basis over the estimated useful lives of the Company’s patents. No amortization is recognized on patent application costs, as amortization of these costs will only commence once the patents have been granted.
Research and Development Costs

Research and Development Costs

 

Research and development costs are expensed as incurred.
Loss per Share and Potentially Dilutive Securities

Loss per Share and Potentially Dilutive Securities

 

Basic loss per share is computed by dividing the net loss available to common stockholders by the weighted average number of common shares outstanding in the period.  Diluted loss per share takes into consideration common shares outstanding (computed under basic earnings per share) and potentially dilutive securities.  The effect of 83,100,000 stock options (September 30, 2019 – 76,450,000), and 8,500,000 warrants (September 30, 2019 – 6,000,000) were not included in the computation of diluted earnings per share for all periods presented because it was anti-dilutive due to the Company’s losses.
Share-Based Compensation

Share-Based Compensation

 

The Company has granted warrants and options to purchase shares of the Company’s common stock to various parties for consulting services.  The fair values of the warrants and options issued have been estimated using the Black-Scholes Option Pricing Model.

 

The Company accounts for stock compensation with persons classified as employees for accounting purposes in accordance with ASC 718 “Compensation – Stock Compensation”, which recognizes awards at fair value on the date of grant and recognition of compensation over the service period for awards expected to vest. Cliff Vesting is used and awards vest on the last day of the vesting period. The fair value of stock options is determined using the Black-Scholes Option Pricing Model. The fair value of common shares issued for services is determined based on the Company’s stock price on the date of issuance.

 

Share-based compensation for non-employees in exchange for goods and services used or consumed in an entity’s own operations are also recorded at fair value on the measurement date and accounted for in accordance with ASC 718. The measurement of share-based compensation is subject to periodic adjustment as the underlying instruments vest. The fair value of stock options is estimated using the Black-Scholes Option Pricing Model and the compensation charges are amortized over the vesting period.
Common stock

Common stock

 

Common stock issued for non-monetary consideration are recorded at their fair value on the measurement date and classified as equity. The measurement date is defined as the earliest of the date at which the commitment for performance by the counterparty to earn the common shares is reached or the date at which the counterparty’s performance is complete.

 

Transaction costs directly attributable to the issuance of common stock, units and stock options are recognized as a deduction from equity, net of any tax effects.
Related Party Transactions

Related Party Transactions

 

A related party is generally defined as (i) any person that holds 10% or more of the Company’s securities and their immediate families, (ii) the Company’s management, (iii) someone that directly or indirectly controls, is controlled by or is under common control with the Company, or (iv) anyone who can significantly influence the financial and operating decisions of the Company.  A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties.
Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

Certain new accounting pronouncements that have been issued are not expected to have a material effect on the Company’s financial statements.
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.20.2
3. Prepaid Expenses (Tables)
 9 Months Ended
Sep. 30, 2020
Prepaid Expense, Current [Abstract]  
Prepaid expenses and deposits outstanding

The following summarizes the Company’s prepaid expenses outstanding as at September 30, 2020 and December 31, 2019:

 

    September 30,
 2020		   December 31,
  2019
         
Rental deposit   $ 1,050     $ 1,050  
                 
    $ 1,050     $ 1,050  
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.20.2
4. Intangible Assets (Tables)
 9 Months Ended
Sep. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible asset transactions

Intangible asset transactions are summarized as follows:

 

    Patent Rights   Patent Application Rights   Total
Cost                        
Balance, December 31, 2018   $ 30,000     $ 168,271     $ 198,271  
Additions     —         22,737       22,737  
Balance, December 31, 2019   $ 30,000     $ 191,008     $ 221,008  
Additions     —         45,380       45,380  
Balance, September 30, 2020   $ 30,000     $ 236,388     $ 266,388  
                         
Accumulated amortization                        
Balance, December 31, 2018   $ 10,500     $ —       $ 10,500  
Amortization     3,000       —         3,000  
Balance, December 31, 2019   $ 13,500     $ —       $ 13,500  
Amortization     2,250       —         2,250  
Balance,September 30, 2020   $ 15,750     $ —       $ 15,750  
                         
Net carrying amounts                        
December 31, 2019   $ 16,500     $ 191,008     $ 207,508  
September 30, 2020   $ 14,250     $ 236,388     $ 250,638  
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.20.2
5. Stock Options (Tables)
 9 Months Ended
Sep. 30, 2020
Stock Options  
Schedule of Share-based Compensation, Stock Options, Activity

Stock option transactions are summarized as follows:

    Number of Stock Options   Weighted Average Exercise Price   Weighted Average Remaining Life
        $   (Years)
Outstanding, December 31, 2019     91,450,000       0.14          
      Options cancelled     (36,000,000 )     0.13          
      Options expired     (2,000,000 )     0.04          
      Options granted     29,650,000       0.13          
Outstanding, September 30, 2020     83,100,000       0.15       4.23  
                         

 

    Number of Stock Options   Weighted Average Exercise Price   Weighted Average Remaining Life
        $   (Years)
Outstanding, December 31, 2018     58,600,000       0.07          
      Options cancelled     (16,000,000 )     0.07          
      Options exercised     (250,000 )      0.07          
      Options granted     34,100,000       0.25          
Outstanding, September 30, 2019     76,450,000       0.15       3.48  
Schedule of valuation assumptions for options

The fair values of the stock options granted were estimated using the Black-Scholes Option Pricing Model, based on the following weighted average assumptions:

 

    September 30, 2020   September 30, 2019
Risk-free interest rate     2.55 %     2.41 %
Dividend yield     0.00 %     0.00 %
Expected stock price volatility     143.57 %     125.00 %
Expected forfeiture rate     0.00 %     0.00 %
Expected life     5.09 years       4.60 years  
Schedule of options by exercise price

The following non-qualified stock options were outstanding and exercisable at September 30, 2020:

 

Expiry date   Exercise Price   Number of Options
Outstanding		   Number of
Options
Exercisable
    $        
December 31, 2020     0.05       1,200,000       1,200,000  
November 14, 2021     0.07       750,000       750,000  
December 31, 2022     0.06       800,000       800,000  
August 31, 2023     0.08       600,000       600,000  
November 8, 2023     0.09       15,000,000       15,000,000  
May 5, 2023     0.13       1,600,000       1,600,000  
July 14, 2024     0.26       18,500,000       18,500,000  
November 17, 2024     0.11       15,000,000       11,250,000  
March 26, 2026     0.14       22,000,000       22,000,000  
May 5, 2026     0.11       650,000       487,500  
June 11, 2026     0.12       7,000,000       7,000,000  
              83,100,000       79,187,500  
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.20.2
6. Warrants (Tables)
 9 Months Ended
Sep. 30, 2020
Warrants  
Schedule of Warrant Activity

Warrant transactions for the nine months ended September 30, 2020 are summarized as follows:

 

    Number of
Warrants		   Weighted
Average Exercise
Price
         
  Balance,December 31, 2018 and September 30, 2019       6,000,000     $ 0.26  
  Balance, December 31, 2019 and September 30, 2020       8,500,000     $ 0.22  
Schedule of Stockholders' Equity Note, Warrants or Rights

The following warrants were outstanding and exercisable as at September 30, 2020:

 

Number of Warrants   Exercise Price ($)   Expiry Date
  6,000,000       0.26     July 14, 2024
  833,333       0.12     October 15, 2022
  250,000       0.12     October 21, 2022
  116,667       0.12     November 11, 2022
  83,334       0.12     November 12, 2022
  833,333       0.12     December 1, 2022
  166,667       0.12     December 18, 2022
  216,666       0.12     December 18, 2022
  8,500,000              
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.20.2
2. Summary of Significant Accounting Policies (Details Narrative) - shares
 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Warrant    
Antidilutive Securities Excluded from Computation of Earnings Per Share 8,500,000 6,000,000
Stock options    
Antidilutive Securities Excluded from Computation of Earnings Per Share 83,100,000 76,450,000
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.20.2
3. Prepaid Expenses (Details) - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Prepaid Expense, Current [Abstract]    
Rental deposit $ 1,050 $ 1,050
Total $ 1,050 $ 1,050
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.20.2
4. Intangible Assets (Details) - USD ($)
 9 Months Ended 12 Months Ended
Sep. 30, 2020
Dec. 31, 2019
Cost    
Beginning balance $ 221,008 $ 198,271
Additions 45,380 22,737
Ending balance 266,388 221,008
Accumulated amortization    
Beginning balance 13,500 10,500
Amortization 2,250 3,000
Ending balance 15,750 13,500
Net carrying amounts 250,638 207,508
Patent Rights [Member]    
Cost    
Beginning balance 30,000 30,000
Additions 0 0
Ending balance 30,000 30,000
Accumulated amortization    
Beginning balance 13,500 10,500
Amortization 2,250 3,000
Ending balance 15,750 13,500
Net carrying amounts 14,250 191,008
Patent Application Rights [Member]    
Cost    
Beginning balance 191,008 168,271
Additions 45,380 22,737
Ending balance 236,388 191,008
Accumulated amortization    
Beginning balance 0 0
Amortization 0 0
Ending balance 0 0
Net carrying amounts $ 236,388 $ 16,500
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.20.2
4. Intangible Assets (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2016
Amortization - intangible assets $ 750 $ 750 $ 2,250 $ 2,250  
Patent Application Rights [Member]          
Direct cost     $ 45,380   $ 2,415
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.20.2
5. Stock Options (Details) - $ / shares
 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Options granted 29,650,000 34,100,000
Outstanding, ending 83,100,000  
Stock options    
Outstanding, beginning 91,450,000 58,600,000
Options cancelled (36,000,000) (16,000,000)
Options expired (2,000,000)  
Options exercised   (250,000)
Options granted 29,650,000 34,100,000
Outstanding, ending 83,100,000 76,450,000
Weighted average exercise price beginning balance $ 0.14 $ .07
Weighted Average Exercise Price, cacelled 0.13 0.07
Weighted Average Exercise Price, expired 0.04  
Weighted Average Exercise Price, Options exercised   0.07
Weighted Average Exercise Price, granted 0.13 0.25
Weighed average exercise price ending balance $ 0.15 $ 0.15
Weighted Average Remaining Life (Years) 4 years 2 months 23 days 3 years 5 months 23 days
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.20.2
5. Stock Options (Details 1)
 3 Months Ended 9 Months Ended
Mar. 25, 2020
Sep. 30, 2020
Sep. 30, 2019
Risk-free interest rate 0.81% 1.76%  
Dividend yield 0.00% 0.00%  
Expected stock price volatility 144.40% 144.75%  
Expected forfeiture rate 0.00% 0.00%  
Expected life 6 years 6 years  
Stock options      
Risk-free interest rate   2.55% 2.41%
Dividend yield   0.00% 0.00%
Expected stock price volatility   143.57% 125.00%
Expected forfeiture rate   0.00% 0.00%
Expected life   5 years 1 month 2 days 4 years 7 months 6 days
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.20.2
5. Stock Options (Details 2) - $ / shares
Sep. 30, 2020
Jun. 12, 2020
Mar. 26, 2020
Outstanding, ending 83,100,000    
Number of options exercisable 79,187,500 7,000,000 22,000,000
December 31, 2020      
Weighed average exercise price ending balance $ 0.05    
Outstanding, ending 1,200,000    
Number of options exercisable 1,200,000    
November 14, 2021      
Weighed average exercise price ending balance $ 0.07    
Outstanding, ending 750,000    
Number of options exercisable 750,000    
December 31, 2022      
Weighed average exercise price ending balance $ 0.06    
Outstanding, ending 800,000    
Number of options exercisable 800,000    
August 31, 2023      
Weighed average exercise price ending balance $ 0.08    
Outstanding, ending 600,000    
Number of options exercisable 600,000    
November 8, 2023      
Weighed average exercise price ending balance $ 0.09    
Outstanding, ending 15,000,000    
Number of options exercisable 15,000,000    
May 5, 2023      
Weighed average exercise price ending balance $ 0.13    
Outstanding, ending 1,600,000    
Number of options exercisable 1,600,000    
July 14, 2024      
Weighed average exercise price ending balance $ 0.26    
Outstanding, ending 18,500,000    
Number of options exercisable 18,500,000    
November 17, 2024      
Weighed average exercise price ending balance $ 0.11    
Outstanding, ending 15,000,000    
Number of options exercisable 11,250,000    
March 26, 2026      
Weighed average exercise price ending balance $ 0.14    
Outstanding, ending 22,000,000    
Number of options exercisable 22,000,000    
May 5, 2026      
Weighed average exercise price ending balance $ 0.11    
Outstanding, ending 650,000    
Number of options exercisable 487,500    
June 11, 2026      
Weighed average exercise price ending balance $ 0.12    
Outstanding, ending 7,000,000    
Number of options exercisable 7,000,000    
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.20.2
5. Stock Options (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Jun. 12, 2020
May 06, 2020
Mar. 26, 2020
Dec. 31, 2019
Aggregate intrinsic value $ 458,165   $ 458,165         $ 1,005,350
Fair value of share-based compensation $ 1,458,990 $ 342,218 $ 6,331,290 $ 1,167,629        
Option description       Options are exercisable at $0.11 per share for a period of six years and expire on May 5, 2026        
Number of options exercisable 79,187,500   79,187,500   7,000,000   22,000,000  
Options granted     29,650,000 34,100,000        
Stock options                
Common stock granted 83,100,000   83,100,000          
Weighted average fair value of stock options granted per share     $ 0.12 $ 0.07        
Options granted     29,650,000 34,100,000        
research and development and Business development                
Common stock granted           650,000    
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.20.2
6. Warrants (Details) - $ / shares
Sep. 30, 2020
Dec. 31, 2019
Sep. 30, 2019
Dec. 31, 2018
Warrants        
Warrant outstanding, ending 8,500,000 8,500,000 6,000,000 6,000,000
Warrant weighted average exercise price $ 0.22 $ 0.22 $ 0.26 $ 0.26
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.20.2
6. Warrants (Details 1) - $ / shares
 9 Months Ended
Sep. 30, 2020
Dec. 31, 2019
Sep. 30, 2019
Dec. 31, 2018
Number of Warrants 8,500,000      
Warrant Exercise Price $ 0.22 $ 0.22 $ 0.26 $ 0.26
Warrant One        
Number of Warrants 6,000,000      
Warrant Exercise Price $ 0.26      
Expiry Date July 14, 2024      
Warrant Two        
Number of Warrants 833,333      
Warrant Exercise Price $ 0.12      
Expiry Date October 15, 2022      
Warrant Three        
Number of Warrants 250,000      
Warrant Exercise Price $ 0.12      
Expiry Date October 21, 2022      
Warrant Four        
Number of Warrants 116,667      
Warrant Exercise Price $ 0.12      
Expiry Date November 11, 2022      
Warrant Five        
Number of Warrants 83,334      
Warrant Exercise Price $ 0.12      
Expiry Date November 12, 2022      
Warrant Six        
Number of Warrants 833,333      
Warrant Exercise Price $ 0.12      
Expiry Date December 1 , 2022      
Warrant Seven        
Number of Warrants 166,667      
Warrant Exercise Price $ 0.12      
Expiry Date December 18, 2022      
Warrant Eight        
Number of Warrants 216,666      
Warrant Exercise Price $ 0.12      
Expiry Date December 18, 2022      
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.20.2
7. Stockholders' Equity (Details Narrative) - USD ($)
 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Common Stock, Par Value Per Share $ 0.0000053   $ 0.0000053
Common Stock, Shares Authorized 400,000,000   400,000,000
Dividends declared $ 0   $ 0
Investors      
Common stock issued 2,222,222 750,000  
Share price $ 0.09 $ 0.06  
Gross proceeds from issue of common stock $ 200,000 $ 45,000  
Investors One      
Common stock issued 320,513    
Gross proceeds from issue of common stock $ 25,000    
Investors One      
Common stock issued   10,000,000  
Share price $ 0.078 $ 0.05  
Gross proceeds from issue of common stock   $ 500,000  
Investors Two      
Common stock issued 3,653,077 2,266,667  
Share price $ 0.065 $ 0.12  
Gross proceeds from issue of common stock $ 237,450 $ 272,000  
Chief Financial Officer [Member]      
Common stock issued   97,826  
Stock options exercise   250,000  
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.20.2
8. Related Party Transactions and Balances (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended
Mar. 25, 2020
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Share based Compensation   $ 502,795 $ 335,197  
Payment to CFO   45,000 45,000  
Due to related parties   $ 0   $ 0
Risk-free interest rate 0.81% 1.76%    
Dividend yield 0.00% 0.00%    
Stock price volatility 144.40% 144.75%    
Forfeiture rate 0.00% 0.00%    
Expected life (years) 6 years 6 years    
Clarence Smith (CEO)        
Share based Compensation $ 282,844 $ 5,704    
Risk-free interest rate 1.76% 1.76%    
Dividend yield 0.00% 0.00%    
Stock price volatility 144.40% 144.75%    
Forfeiture rate 0.00% 0.00%    
Expected life (years) 6 years 6 years    
Chief Financial Officer [Member]        
Office rent   $ 9,450 $ 9,450  
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.20.2
9. Commitments and Contingency (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended
Mar. 25, 2020
Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]    
Share-based compensation $ 235,703  
Risk-free interest rate 0.81% 1.76%
Dividend yield 0.00% 0.00%
Stock price volatility 144.40% 144.75%
Forfeiture rate 0.00% 0.00%
Expected life (years) 6 years 6 years
EXCEL 44 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 46 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 47 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 108 210 1 false 33 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://protokinetix.com/taxonomy/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - BALANCE SHEETS (Unaudited) Sheet http://protokinetix.com/role/BalanceSheets BALANCE SHEETS (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - BALANCE SHEETS (Unaudited) (Parenthetical) Sheet http://protokinetix.com/role/BalanceSheetsParenthetical BALANCE SHEETS (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - STATEMENTS OF OPERATIONS (Unaudited) Sheet http://protokinetix.com/role/StatementsOfOperations STATEMENTS OF OPERATIONS (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - STATEMENT OF STOCKHOLDERS??? EQUITY (Unaudited) Sheet http://protokinetix.com/role/StatementOfStockholdersEquity STATEMENT OF STOCKHOLDERS??? EQUITY (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://protokinetix.com/role/StatementsOfCashFlows STATEMENTS OF CASH FLOWS (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - 1. Basis of Presentation - Going Concern Uncertainties Sheet http://protokinetix.com/role/BasisOfPresentation-GoingConcernUncertainties 1. Basis of Presentation - Going Concern Uncertainties Notes 7 false false R8.htm 00000008 - Disclosure - 2. Summary of Significant Accounting Policies Sheet http://protokinetix.com/role/SummaryOfSignificantAccountingPolicies 2. Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - 3. Prepaid Expenses Sheet http://protokinetix.com/role/PrepaidExpensesAndDeposits 3. Prepaid Expenses Notes 9 false false R10.htm 00000010 - Disclosure - 4. Intangible Assets Sheet http://protokinetix.com/role/IntangibleAssets 4. Intangible Assets Notes 10 false false R11.htm 00000011 - Disclosure - 5. Stock Options Sheet http://protokinetix.com/role/StockOptions 5. Stock Options Notes 11 false false R12.htm 00000012 - Disclosure - 6. Warrants Sheet http://protokinetix.com/role/Warrants 6. Warrants Notes 12 false false R13.htm 00000013 - Disclosure - 7. Stockholders' Equity Sheet http://protokinetix.com/role/StockholdersEquity 7. Stockholders' Equity Notes 13 false false R14.htm 00000014 - Disclosure - 8. Related Party Transactions and Balances Sheet http://protokinetix.com/role/RelatedPartyTransactionsAndBalances 8. Related Party Transactions and Balances Notes 14 false false R15.htm 00000015 - Disclosure - 9. Commitments and Contingency Sheet http://protokinetix.com/role/CommitmentsAndContingency 9. Commitments and Contingency Notes 15 false false R16.htm 00000016 - Disclosure - 2. Summary of Significant Accounting Policies (Policies) Sheet http://protokinetix.com/role/SummaryOfSignificantAccountingPoliciesPolicies 2. Summary of Significant Accounting Policies (Policies) Policies http://protokinetix.com/role/SummaryOfSignificantAccountingPolicies 16 false false R17.htm 00000017 - Disclosure - 3. Prepaid Expenses (Tables) Sheet http://protokinetix.com/role/PrepaidExpensesAndDepositsTables 3. Prepaid Expenses (Tables) Tables http://protokinetix.com/role/PrepaidExpensesAndDeposits 17 false false R18.htm 00000018 - Disclosure - 4. Intangible Assets (Tables) Sheet http://protokinetix.com/role/IntangibleAssetsTables 4. Intangible Assets (Tables) Tables http://protokinetix.com/role/IntangibleAssets 18 false false R19.htm 00000019 - Disclosure - 5. Stock Options (Tables) Sheet http://protokinetix.com/role/StockOptionsTables 5. Stock Options (Tables) Tables http://protokinetix.com/role/StockOptions 19 false false R20.htm 00000020 - Disclosure - 6. Warrants (Tables) Sheet http://protokinetix.com/role/WarrantsTables 6. Warrants (Tables) Tables http://protokinetix.com/role/Warrants 20 false false R21.htm 00000021 - Disclosure - 2. Summary of Significant Accounting Policies (Details Narrative) Sheet http://protokinetix.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative 2. Summary of Significant Accounting Policies (Details Narrative) Details http://protokinetix.com/role/SummaryOfSignificantAccountingPoliciesPolicies 21 false false R22.htm 00000022 - Disclosure - 3. Prepaid Expenses (Details) Sheet http://protokinetix.com/role/PrepaidExpensesDetails 3. Prepaid Expenses (Details) Details http://protokinetix.com/role/PrepaidExpensesAndDepositsTables 22 false false R23.htm 00000023 - Disclosure - 4. Intangible Assets (Details) Sheet http://protokinetix.com/role/IntangibleAssetsDetails 4. Intangible Assets (Details) Details http://protokinetix.com/role/IntangibleAssetsTables 23 false false R24.htm 00000024 - Disclosure - 4. Intangible Assets (Details Narrative) Sheet http://protokinetix.com/role/IntangibleAssetsDetailsNarrative 4. Intangible Assets (Details Narrative) Details http://protokinetix.com/role/IntangibleAssetsTables 24 false false R25.htm 00000025 - Disclosure - 5. Stock Options (Details) Sheet http://protokinetix.com/role/StockOptionsDetails 5. Stock Options (Details) Details http://protokinetix.com/role/StockOptionsTables 25 false false R26.htm 00000026 - Disclosure - 5. Stock Options (Details 1) Sheet http://protokinetix.com/role/StockOptionsDetails1 5. Stock Options (Details 1) Details http://protokinetix.com/role/StockOptionsTables 26 false false R27.htm 00000027 - Disclosure - 5. Stock Options (Details 2) Sheet http://protokinetix.com/role/StockOptionsDetails2 5. Stock Options (Details 2) Details http://protokinetix.com/role/StockOptionsTables 27 false false R28.htm 00000028 - Disclosure - 5. Stock Options (Details Narrative) Sheet http://protokinetix.com/role/StockOptionsDetailsNarrative 5. Stock Options (Details Narrative) Details http://protokinetix.com/role/StockOptionsTables 28 false false R29.htm 00000029 - Disclosure - 6. Warrants (Details) Sheet http://protokinetix.com/role/WarrantsDetails 6. Warrants (Details) Details http://protokinetix.com/role/WarrantsTables 29 false false R30.htm 00000030 - Disclosure - 6. Warrants (Details 1) Sheet http://protokinetix.com/role/WarrantsDetails1 6. Warrants (Details 1) Details http://protokinetix.com/role/WarrantsTables 30 false false R31.htm 00000031 - Disclosure - 7. Stockholders' Equity (Details Narrative) Sheet http://protokinetix.com/role/StockholdersEquityDetailsNarrative 7. Stockholders' Equity (Details Narrative) Details http://protokinetix.com/role/StockholdersEquity 31 false false R32.htm 00000032 - Disclosure - 8. Related Party Transactions and Balances (Details Narrative) Sheet http://protokinetix.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative 8. Related Party Transactions and Balances (Details Narrative) Details http://protokinetix.com/role/RelatedPartyTransactionsAndBalances 32 false false R33.htm 00000033 - Disclosure - 9. Commitments and Contingency (Details Narrative) Sheet http://protokinetix.com/role/CommitmentsAndContingencyDetailsNarrative 9. Commitments and Contingency (Details Narrative) Details http://protokinetix.com/role/CommitmentsAndContingency 33 false false All Reports Book All Reports pktx-20200930.xml pktx-20200930.xsd pktx-20200930_cal.xml pktx-20200930_def.xml pktx-20200930_lab.xml pktx-20200930_pre.xml http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/us-gaap/2019-01-31 http://fasb.org/srt/2019-01-31 true true ZIP 49 0001079973-20-000888-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001079973-20-000888-xbrl.zip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end